Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI
NC_000023.11:g.153714363_153781647del	ABCD1|BCAP31|LOC130068830|LOC130068831|LOC130068832|LOC130068833|LOC130068834|PLXNB3|PLXNB3-AS1|SRPK3		Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome	Pathogenic	criteria provided, single submitter	VCV002500712			X	153714363 - 153781647	2500712	2523610		
GRCh37/hg19 Xq28(chrX:152980470-153032459)	ABCD1|BCAP31|PLXNB3		Adrenoleukodystrophy|Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625802	X	152980470 - 153032459			625802	614106		
NM_001101.5(ACTB):c.547C>T (p.Arg183Trp)	ACTB	R183W	ACTB-related BAFopathy|Inborn genetic diseases|not provided|Baraitser-Winter syndrome 1|Developmental malformations-deafness-dystonia syndrome	Pathogenic(Last reviewed: Dec 7, 2022)	criteria provided, multiple submitters, no conflicts	VCV000018275	7	5568167	7	5528536	18275	33314	rs104894003	NC_000007.14:5528535:G:A
NC_000005.9:g.(?_218471)_(1895829_?)del	AHRR|BRD9|CEP72|CLPTM1L|EXOC3|EXOC3-AS1|IRX4|LPCAT1|MRPL36|NDUFS6|NKD2|PDCD6|SDHA|SLC12A7|SLC6A18|SLC6A19|SLC6A3|SLC9A3|TERT|TPPP|TRIP13|ZDHHC11|ZDHHC11B		Parkinsonism-dystonia, infantile	Pathogenic(Last reviewed: Oct 2, 2022)	criteria provided, single submitter	VCV001459245	5	218471 - 1895829			1459245	1406372		
NM_031418.4(ANO3):c.1528G>A (p.Glu510Lys)	ANO3	E364K, E510K, E571K	Dystonia 24|Dystonic disorder	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000641954	11	26619992	11	26598445	641954	639919	rs1590612392	NC_000011.10:26598444:G:A
NM_031418.4(ANO3):c.2586G>T (p.Lys862Asn)	ANO3	K862N, K923N, K716N	Dystonia 24	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039499	11	26677681	11	26656134	39499	48098	rs1277790116	NC_000011.10:26656133:G:T
NM_031418.4(ANO3):c.2053A>G (p.Ser685Gly)	ANO3	S685G, S746G, S539G	Dystonia 24	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039498	11	26660700	11	26639153	39498	48097	rs587776923	NC_000011.10:26639152:A:G
NM_031418.4(ANO3):c.1470G>T (p.Trp490Cys)	ANO3	W490C, W551C, W344C	Dystonia 24	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039497	11	26619934	11	26598387	39497	48096	rs1565132917	NC_000011.10:26598386:G:T
NM_031418.4(ANO3):c.1480A>T (p.Arg494Trp)	ANO3	R494W, R555W, R348W	Dystonia 24	Pathogenic(Last reviewed: Dec 7, 2012)	no assertion criteria provided	VCV000039496	11	26619944	11	26598397	39496	48095	rs587776922	NC_000011.10:26598396:A:T
NM_001193329.3(AOPEP):c.964+2T>G	AOPEP		Dystonia 31	Pathogenic	criteria provided, single submitter	VCV002663844	9	97535452	9	94773170	2663844	2831293		NC_000009.12:94773169:T:G
NM_001193329.3(AOPEP):c.1744del (p.Met582fs)	AOPEP	M152fs, M475fs, M483fs, M582fs	Dystonia 31	Pathogenic	criteria provided, single submitter	VCV001319963	9	97717541	9	94955259	1319963	1310211		NC_000009.12:94955258:A:
NM_001193329.3(AOPEP):c.763C>T (p.Arg255Ter)	AOPEP	R255*	Dystonia 31	Pathogenic(Last reviewed: Jan 28, 2022)	no assertion criteria provided	VCV001319961	9	97522828	9	94760546	1319961	1310209		NC_000009.12:94760545:C:T
NM_001193329.3(AOPEP):c.777G>A (p.Trp259Ter)	AOPEP	W259*	Dystonia 31	Pathogenic(Last reviewed: Jan 28, 2022)	no assertion criteria provided	VCV001319960	9	97522842	9	94760560	1319960	1310208		NC_000009.12:94760559:G:A
NM_001193329.3(AOPEP):c.1477C>T (p.Arg493Ter)	AOPEP	R493*, R203*, R386*	Dystonia 31	Pathogenic(Last reviewed: Jan 28, 2022)	no assertion criteria provided	VCV001319959	9	97686380	9	94924098	1319959	1310207		NC_000009.12:94924097:C:T
GRCh37/hg19 7q21.3(chr7:93516132-95668733)	ASB4|BET1|CASD1|COL1A2|DYNC1I1|GNG11|GNGT1|PDK4|PEG10|PON1|PON2|PON3|PPP1R9A|SGCE|TFPI2		Myoclonic dystonia 11	Pathogenic(Last reviewed: Jul 1, 2020)	criteria provided, single submitter	VCV000976777	7	93516132 - 95668733			976777	964914		
NM_152296.5(ATP1A3):c.1079C>G (p.Thr360Arg)	ATP1A3	T360R, T371R, T373R	Alternating hemiplegia of childhood 2|Dystonia 12	Pathogenic/Likely pathogenic(Last reviewed: Apr 20, 2023)	criteria provided, multiple submitters, no conflicts	VCV002499589	19	42486173	19	41982021	2499589	2477571		NC_000019.10:41982020:G:C
NC_000019.9:g.(?_42471089)_(42486278_?)del	ATP1A3		Dystonia 12	Pathogenic(Last reviewed: Aug 27, 2022)	criteria provided, single submitter	VCV002427356	19	42471089 - 42486278			2427356	1950131		
NC_000019.9:g.(?_42489050)_(42490401_?)del	ATP1A3		Dystonia 12	Pathogenic(Last reviewed: Oct 5, 2022)	criteria provided, single submitter	VCV002427355	19	42489050 - 42490401			2427355	1950130		
NC_000019.9:g.(?_42479761)_(42492734_?)del	ATP1A3		Dystonia 12	Pathogenic(Last reviewed: Mar 13, 2022)	criteria provided, single submitter	VCV002427354	19	42479761 - 42492734			2427354	1950129		
NM_152296.5(ATP1A3):c.2224GAC[1] (p.Asp743del)	ATP1A3	D743del, D754del, D756del	Dystonia 12	Pathogenic(Last reviewed: Feb 7, 2022)	criteria provided, single submitter	VCV002152317	19	42479815 - 42479817	19	41975663 - 41975665	2152317	1892388		NC_000019.10:41975662:GTCGTC:GTC
NM_152296.5(ATP1A3):c.2263G>A (p.Gly755Ser)	ATP1A3	G755S, G766S, G768S	Dystonia 12	Pathogenic(Last reviewed: Mar 25, 2022)	criteria provided, single submitter	VCV002138303	19	42479781	19	41975629	2138303	170988	rs557052809	NC_000019.10:41975628:C:T
NM_152296.5(ATP1A3):c.2966_2996del (p.Phe989fs)	ATP1A3	F1002fs, F1000fs, F989fs	Dystonia 12	Pathogenic(Last reviewed: May 7, 2022)	criteria provided, single submitter	VCV002111919	19	42471418 - 42471448	19	41967266 - 41967296	2111919	2160740		NC_000019.10:41967265:AGGATGAGTTTGCGGATTTCGTCGTAGACGAAG:AG
NM_152296.5(ATP1A3):c.2759A>C (p.Gln920Pro)	ATP1A3	Q933P, Q931P, Q920P	Dystonia 12	Pathogenic(Last reviewed: Aug 15, 2022)	criteria provided, single submitter	VCV002049263	19	42472997	19	41968845	2049263	2111032		NC_000019.10:41968844:T:G
NM_152296.5(ATP1A3):c.1784_1792del (p.Lys595_Arg597del)	ATP1A3		Dystonia 12	Pathogenic(Last reviewed: Aug 24, 2022)	criteria provided, single submitter	VCV002026932	19	42482317 - 42482325	19	41978165 - 41978173	2026932	2084852		NC_000019.10:41978164:TGCGACACTTGC:TGC
NM_152296.5(ATP1A3):c.1299del (p.Lys434fs)	ATP1A3	K434fs, K445fs, K447fs	Dystonia 12	Pathogenic(Last reviewed: Aug 21, 2022)	criteria provided, single submitter	VCV002025830	19	42485877	19	41981725	2025830	2081178		NC_000019.10:41981724:G:
NM_152296.5(ATP1A3):c.281T>C (p.Leu94Pro)	ATP1A3	L107P, L105P, L94P	Dystonia 12	Pathogenic(Last reviewed: Jun 1, 2022)	criteria provided, single submitter	VCV001992440	19	42492164	19	41988012	1992440	2058962		NC_000019.10:41988011:A:G
NM_152296.5(ATP1A3):c.2116G>C (p.Gly706Arg)	ATP1A3	G717R, G706R, G719R	Dystonia 12	Pathogenic(Last reviewed: Jul 23, 2022)	criteria provided, single submitter	VCV001918208	19	42479928	19	41975776	1918208	1978419		NC_000019.10:41975775:C:G
NM_152296.5(ATP1A3):c.2225A>T (p.Asp742Val)	ATP1A3	D742V, D753V, D755V	Dystonia 12	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001685558	19	42479819	19	41975667	1685558	1677575		NC_000019.10:41975666:T:A
NM_152296.5(ATP1A3):c.2767G>C (p.Asp923His)	ATP1A3	D923H, D934H, D936H	Dystonia 12	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001685557	19	42472989	19	41968837	1685557	1677574		NC_000019.10:41968836:C:G
NM_152296.5(ATP1A3):c.1959C>A (p.Cys653Ter)	ATP1A3	C664*, C653*, C666*	Dystonia 12	Pathogenic(Last reviewed: Dec 1, 2021)	criteria provided, single submitter	VCV001434538	19	42480703	19	41976551	1434538	1494354		NC_000019.10:41976550:G:T
NM_152296.5(ATP1A3):c.2652dup (p.Val885fs)	ATP1A3	V898fs, V885fs, V896fs	Dystonia 12	Pathogenic(Last reviewed: Dec 21, 2021)	criteria provided, single submitter	VCV001414742	19	42473622 - 42473623	19	41969470 - 41969471	1414742	1369944		NC_000019.10:41969470:GG:GGG
NM_152296.5(ATP1A3):c.1429A>T (p.Lys477Ter)	ATP1A3	K490*, K477*, K488*	Dystonia 12	Pathogenic(Last reviewed: Nov 12, 2021)	criteria provided, single submitter	VCV001357866	19	42485662	19	41981510	1357866	1367761		NC_000019.10:41981509:T:A
NM_152296.5(ATP1A3):c.1088T>C (p.Ile363Thr)	ATP1A3	I363T, I374T, I376T	Dystonia 12	Pathogenic(Last reviewed: Oct 28, 2022)	criteria provided, single submitter	VCV001264343	19	42486164	19	41982012	1264343	1254243		NC_000019.10:41982011:A:G
NM_152296.5(ATP1A3):c.2677G>A (p.Gly893Arg)	ATP1A3	G893R, G904R, G906R	Dystonia 12|not provided	Pathogenic(Last reviewed: Jun 26, 2023)	criteria provided, multiple submitters, no conflicts	VCV001187017	19	42473598	19	41969446	1187017	1178389		NC_000019.10:41969445:C:T
NM_152296.5(ATP1A3):c.1073G>A (p.Gly358Asp)	ATP1A3	G358D, G369D, G371D	Dystonia 12	Pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV001075560	19	42486179	19	41982027	1075560	1064725		NC_000019.10:41982026:C:T
NM_152296.5(ATP1A3):c.1072G>A (p.Gly358Ser)	ATP1A3	G358S, G369S, G371S	Dystonia 12	Pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV001069208	19	42486180	19	41982028	1069208	1064726		NC_000019.10:41982027:C:T
NM_152296.5(ATP1A3):c.3013+1G>A	ATP1A3		Dystonia 12	Pathogenic(Last reviewed: Dec 6, 2021)	criteria provided, single submitter	VCV001059801	19	42471400	19	41967248	1059801	1051341		NC_000019.10:41967247:C:T
NM_152296.5(ATP1A3):c.562C>T (p.Arg188Ter)	ATP1A3	R188*, R199*, R201*	Dystonia 12	Pathogenic(Last reviewed: Dec 1, 2021)	criteria provided, single submitter	VCV001001291	19	42490060	19	41985908	1001291	998642	rs2075282510	NC_000019.10:41985907:G:A
NM_152296.5(ATP1A3):c.2768A>C (p.Asp923Ala)	ATP1A3	D923A, D934A, D936A	Dystonia 12	Pathogenic(Last reviewed: Oct 13, 2022)	criteria provided, single submitter	VCV000962099	19	42472988	19	41968836	962099	950810	rs2075071528	NC_000019.10:41968835:T:G
NM_152296.5(ATP1A3):c.1930C>T (p.Gln644Ter)	ATP1A3	Q644*, Q655*, Q657*	Dystonia 12	Pathogenic(Last reviewed: Nov 1, 2021)	criteria provided, single submitter	VCV000944204	19	42482101	19	41977949	944204	928983	rs1555861946	NC_000019.10:41977948:G:A
NM_152296.5(ATP1A3):c.954C>G (p.Ile318Met)	ATP1A3	I318M, I329M, I331M	Dystonia 12|Alternating hemiplegia of childhood 2|Dystonia 12	Pathogenic(Last reviewed: Aug 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000929469	19	42489109	19	41984957	929469	917793	rs529241207	NC_000019.10:41984956:G:C
NM_152296.5(ATP1A3):c.2542+1G>C	ATP1A3		Dystonia 12	Pathogenic(Last reviewed: Sep 6, 2022)	criteria provided, single submitter	VCV000846620	19	42474336	19	41970184	846620	852336	rs606231441	NC_000019.10:41970183:C:G
NC_000019.10:g.(?_41968775)_(41970552_?)del	ATP1A3		Dystonia 12	Pathogenic(Last reviewed: Nov 1, 2021)	criteria provided, single submitter	VCV000831696	19	42472927 - 42474704			831696	821261		
NM_152296.5(ATP1A3):c.266G>C (p.Gly89Ala)	ATP1A3	G102A, G100A, G89A	not provided|Dystonia 12	Pathogenic/Likely pathogenic(Last reviewed: Apr 5, 2023)	criteria provided, multiple submitters, no conflicts	VCV000807379	19	42492179	19	41988027	807379	798755	rs1599725621	NC_000019.10:41988026:C:G
NM_152296.5(ATP1A3):c.2839G>T (p.Gly947Trp)	ATP1A3	G947W, G958W, G960W	Dystonia 12|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome|Dystonia 12|Alternating hemiplegia of childhood 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000689735	19	42471896	19	41967744	689735	677461	rs398122887	NC_000019.10:41967743:C:A
NM_152296.5(ATP1A3):c.958G>C (p.Ala320Pro)	ATP1A3	A320P, A331P, A333P	Dystonia 12|Delayed speech and language development|Apnea|Seizure|Hemiplegia|Oculogyric crisis	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000523558	19	42489105	19	41984953	523558	514099	rs879255368	NC_000019.10:41984952:C:G
NM_152296.5(ATP1A3):c.2771T>C (p.Leu924Pro)	ATP1A3	L924P, L935P, L937P	Dystonia 12|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000520712	19	42472985	19	41968833	520712	512420	rs1555859157	NC_000019.10:41968832:A:G
NM_152296.5(ATP1A3):c.2408G>A (p.Gly803Asp)	ATP1A3	G803D, G816D, G814D	Dystonia 12	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000468598	19	42474550	19	41970398	468598	469865	rs1555859571	NC_000019.10:41970397:C:T
NM_152296.5(ATP1A3):c.977T>G (p.Leu326Arg)	ATP1A3	L326R, L337R, L339R	not provided|Dystonia 12	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000429300	19	42489086	19	41984934	429300	422287	rs1131691307	NC_000019.10:41984933:A:C
NM_152296.5(ATP1A3):c.2266C>T (p.Arg756Cys)	ATP1A3	R756C, R767C, R769C	Alternating hemiplegia of childhood 2|Dystonia 12|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome|Alternating hemiplegia of childhood 2|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome|not provided|Dystonia 12|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: May 25, 2023)	criteria provided, multiple submitters, no conflicts	VCV000425189	19	42474692	19	41970540	425189	413523	rs1064797245	NC_000019.10:41970539:G:A
NM_152296.5(ATP1A3):c.2315G>A (p.Ser772Asn)	ATP1A3	S772N, S783N, S785N	not provided|Dystonia 12	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000421593	19	42474643	19	41970491	421593	410623	rs1064795234	NC_000019.10:41970490:C:T
NM_152296.5(ATP1A3):c.2763G>A (p.Trp921Ter)	ATP1A3	W921*, W932*, W934*	Dystonia 12	Pathogenic(Last reviewed: Dec 1, 2021)	criteria provided, single submitter	VCV000406192	19	42472993	19	41968841	406192	403758	rs1060500993	NC_000019.10:41968840:C:T
NM_152296.5(ATP1A3):c.385G>A (p.Val129Met)	ATP1A3	V129M, V142M, V140M	Juvenile onset psychosis|not provided|Alternating hemiplegia of childhood 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000267411	19	42490354	19	41986202	267411	262636	rs1555865401	NC_000019.10:41986201:C:T
NM_152296.5(ATP1A3):c.946G>A (p.Gly316Ser)	ATP1A3	G316S, G327S, G329S	ATP1A3-Related Disorders	Pathogenic	criteria provided, single submitter	VCV000225200	19	42489117	19	41984965	225200	227128	rs869320661	NC_000019.10:41984964:C:T
NM_152296.5(ATP1A3):c.3035ACT[3] (p.Tyr1013dup)	ATP1A3		Dystonia 12	Pathogenic(Last reviewed: Jul 1, 2009)	no assertion criteria provided	VCV000161154	19	42471090 - 42471091	19	41966938 - 41966939	161154	170965	rs397515382	NC_000019.10:41966938:AGTAGTAG:AGTAGTAGTAG
NM_152296.5(ATP1A3):c.2767G>T (p.Asp923Tyr)	ATP1A3	D923Y, D936Y, D934Y	Dystonia 12|not provided	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000161148	19	42472989	19	41968837	161148	170971	rs267606670	NC_000019.10:41968836:C:A
NM_152296.5(ATP1A3):c.2752GTC[1] (p.Val919del)	ATP1A3	V919del, V930del, V932del	Dystonia 12	Pathogenic(Last reviewed: Feb 11, 2022)	criteria provided, single submitter	VCV000161147	19	42472999 - 42473001	19	41968847 - 41968849	161147	170972	rs606231443	NC_000019.10:41968846:GACGAC:GAC
NM_152296.5(ATP1A3):c.2600G>A (p.Gly867Asp)	ATP1A3	G867D, G878D, G880D	not provided	Pathogenic(Last reviewed: Mar 8, 2022)	criteria provided, single submitter	VCV000161146	19	42473675	19	41969523	161146	170973	rs606231442	NC_000019.10:41969522:C:T
NM_152296.5(ATP1A3):c.2542+1G>A	ATP1A3		Dystonia 12	Pathogenic(Last reviewed: Nov 22, 2021)	criteria provided, single submitter	VCV000161145	19	42474336	19	41970184	161145	170974	rs606231441	NC_000019.10:41970183:C:T
NM_152296.5(ATP1A3):c.2415C>G (p.Asp805Glu)	ATP1A3	D805E, D816E, D818E	Dystonia 12	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV000161141	19	42474543	19	41970391	161141	170978	rs606231439	NC_000019.10:41970390:G:C
NM_152296.5(ATP1A3):c.2318A>G (p.Asn773Ser)	ATP1A3	N773S, N786S, N784S	Alternating hemiplegia of childhood 2|not provided|Dystonia 12	Pathogenic(Last reviewed: Aug 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000161138	19	42474640	19	41970488	161138	170981	rs606231437	NC_000019.10:41970487:T:C
NM_152296.5(ATP1A3):c.2267G>A (p.Arg756His)	ATP1A3	R756H, R769H, R767H	ATP1A3-associated neurological disorder|Inborn genetic diseases|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome|not specified|not provided|Alternating hemiplegia of childhood 2|Dystonia 12	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2023)	criteria provided, multiple submitters, no conflicts	VCV000161134	19	42474691	19	41970539	161134	170985	rs606231435	NC_000019.10:41970538:C:T
NM_152296.5(ATP1A3):c.2263G>T (p.Gly755Cys)	ATP1A3	G755C, G766C, G768C	not provided|Dystonia 12	Pathogenic(Last reviewed: Aug 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000161133	19	42479781	19	41975629	161133	170987	rs557052809	NC_000019.10:41975628:C:A
NM_152296.5(ATP1A3):c.2264G>C (p.Gly755Ala)	ATP1A3	G755A, G768A, G766A	Dystonia 12	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000161131	19	42474694	19	41970542	161131	170986	rs606231434	NC_000019.10:41970541:C:G
NM_152296.5(ATP1A3):c.1072G>T (p.Gly358Cys)	ATP1A3	G358C, G369C, G371C	Dystonia 12	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000161129	19	42486180	19	41982028	161129	170993	rs606231432	NC_000019.10:41982027:C:A
NM_152296.5(ATP1A3):c.410C>T (p.Ser137Phe)	ATP1A3	S137F, S150F, S148F	not provided|Alternating hemiplegia of childhood 2|Dystonia 12|Ventriculomegaly|Abnormal earlobe morphology|Depressed nasal bridge|Seizure|Epicanthus	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000161122	19	42490329	19	41986177	161122	171000	rs542652468	NC_000019.10:41986176:G:A
NM_152296.5(ATP1A3):c.410C>A (p.Ser137Tyr)	ATP1A3	S137Y, S150Y, S148Y	Dystonia 12	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000161121	19	42490329	19	41986177	161121	171001	rs542652468	NC_000019.10:41986176:G:T
NM_152296.5(ATP1A3):c.2452G>A (p.Glu818Lys)	ATP1A3	E818K, E829K, E831K	Inborn genetic diseases|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome|not provided|Alternating hemiplegia of childhood 2|Dystonia 12	Pathogenic(Last reviewed: Mar 16, 2023)	criteria provided, multiple submitters, no conflicts	VCV000156238	19	42474427	19	41970275	156238	166024	rs587777771	NC_000019.10:41970274:C:T
NM_152296.5(ATP1A3):c.2839G>C (p.Gly947Arg)	ATP1A3	G947R, G958R, G960R	Dystonia 12	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000139579	19	42471896	19	41967744	139579	143209	rs398122887	NC_000019.10:41967743:C:G
NM_152296.5(ATP1A3):c.2839G>A (p.Gly947Arg)	ATP1A3	G947R, G958R, G960R	Dystonia 12|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome|Alternating hemiplegia of childhood 2|not provided|Alternating hemiplegia of childhood 2|Dystonia 12	Pathogenic(Last reviewed: Apr 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000037110	19	42471896	19	41967744	37110	45780	rs398122887	NC_000019.10:41967743:C:T
NM_152296.5(ATP1A3):c.2431T>C (p.Ser811Pro)	ATP1A3	S811P, S824P, S822P	Dystonia 12	Pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV000037109	19	42474448	19	41970296	37109	45779	rs387907282	NC_000019.10:41970295:A:G
NM_152296.5(ATP1A3):c.2443G>A (p.Glu815Lys)	ATP1A3	E815K, E826K, E828K	Inborn genetic diseases|Dystonia 12|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome|Alternating hemiplegia of childhood 2|Seizure|Neurodevelopmental delay|Dystonic disorder|Dyskinesia|Developmental and epileptic encephalopathy 99|not specified|not provided|Alternating hemiplegia of childhood 2|Dystonia 12|Global developmental delay|Oculogyric crisis|Hemiplegia	Pathogenic(Last reviewed: Dec 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000037108	19	42474436	19	41970284	37108	45778	rs387907281	NC_000019.10:41970283:C:T
NM_152296.5(ATP1A3):c.2401G>A (p.Asp801Asn)	ATP1A3	D801N, D812N, D814N	Inborn genetic diseases|Dystonia 12|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome|Alternating hemiplegia of childhood 2|ATP1A3-Related Disorders|not provided|Alternating hemiplegia of childhood 2|Dystonia 12	Pathogenic(Last reviewed: Sep 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV000037107	19	42474557	19	41970405	37107	45777		NC_000019.10:41970404:C:T
NM_152296.5(ATP1A3):c.2767G>A (p.Asp923Asn)	ATP1A3	D923N, D936N, D934N	ATP1A3-associated neurological disorder|Dystonia 12|Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome|Alternating hemiplegia of childhood 2|not provided|Alternating hemiplegia of childhood 2|Dystonia 12	Pathogenic(Last reviewed: Aug 10, 2023)	criteria provided, multiple submitters, no conflicts	VCV000012915	19	42472989	19	41968837	12915	27954	rs267606670	NC_000019.10:41968836:C:T
NM_152296.5(ATP1A3):c.2401G>T (p.Asp801Tyr)	ATP1A3	D801Y, D812Y, D814Y	Dystonia 12	Pathogenic(Last reviewed: Sep 14, 2022)	criteria provided, single submitter	VCV000012914	19	42474557	19	41970405	12914	27953	rs80356537	NC_000019.10:41970404:C:A
NM_152296.5(ATP1A3):c.2338T>C (p.Phe780Leu)	ATP1A3	F780L, F793L, F791L	Dystonia 12	Pathogenic(Last reviewed: Jul 7, 2006)	no assertion criteria provided	VCV000012913	19	42474620	19	41970468	12913	27952	rs80356536	NC_000019.10:41970467:A:G
NM_152296.5(ATP1A3):c.829G>A (p.Glu277Lys)	ATP1A3	E277K, E290K, E288K	Dystonia 12	Pathogenic(Last reviewed: May 16, 2023)	criteria provided, multiple submitters, no conflicts	VCV000012911	19	42489234	19	41985082	12911	27950	rs80356533	NC_000019.10:41985081:C:T
NM_152296.5(ATP1A3):c.821T>C (p.Ile274Thr)	ATP1A3	I274T, I287T, I285T	Dystonia 12	Pathogenic(Last reviewed: Jul 22, 2004)	no assertion criteria provided	VCV000012910	19	42489242	19	41985090	12910	27949	rs80356532	NC_000019.10:41985089:A:G
NM_152296.5(ATP1A3):c.1838C>T (p.Thr613Met)	ATP1A3	T613M, T626M, T624M	not provided|Alternating hemiplegia of childhood 2|Dystonia 12	Pathogenic(Last reviewed: May 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000012909	19	42482193	19	41978041	12909	27948		NC_000019.10:41978040:G:A
NM_001689.5(ATP5MC3):c.236G>T (p.Gly79Val)	ATP5MC3	G79V	Dystonia, early-onset, and/or spastic paraplegia	Pathogenic(Last reviewed: May 4, 2023)	no assertion criteria provided	VCV002500984	2	176043863	2	175179135	2500984	2523879		NC_000002.12:175179134:C:A
NM_001689.5(ATP5MC3):c.319C>G (p.Pro107Ala)	ATP5MC3	P107A	Dystonia, early-onset, and/or spastic paraplegia	Pathogenic(Last reviewed: May 4, 2023)	no assertion criteria provided	VCV002500983	2	176043126	2	175178398	2500983	2523878		NC_000002.12:175178397:G:C
NM_001256447.2(BCAP31):c.415C>T (p.Gln139Ter)	BCAP31	Q139*, Q206*	Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804102	X	152969476	X	153704021	804102	792141	rs1603223001	NC_000023.11:153704020:G:A
NM_001256447.2(BCAP31):c.365_366del (p.Leu122fs)	BCAP31	L122fs, L189fs	Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488474	X	152969525 - 152969526	X	153704070 - 153704071	488474	481342	rs1557047954	NC_000023.11:153704069:GAGAG:GAG
NM_001256447.2(BCAP31):c.341+2T>G	BCAP31		not provided	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000419708	X	152980995	X	153715540	419708	411155	rs1064794057	NC_000023.11:153715539:A:C
NM_001256447.2(BCAP31):c.-44-270C>A	BCAP31	S36*	Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome	Pathogenic(Last reviewed: Jun 17, 2014)	no assertion criteria provided	VCV000374401	X	152989013	X	153723558	374401	361238	rs1057518721	NC_000023.11:153723557:G:T
NM_001256447.2(BCAP31):c.97C>T (p.Gln33Ter)	BCAP31	Q33*, Q100*	Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000068446	X	152986423	X	153720968	68446	79337	rs397515620	NC_000023.11:153720967:G:A
NC_000023.11:g.153696346_153701690del	BCAP31|SLC6A8		Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000068445	X	152961800 - 152967144	X	153696345 - 153701689	68445	79336		
NM_001256447.2(BCAP31):c.194-2A>G	BCAP31		Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	no assertion criteria provided	VCV000068444	X	152981146	X	153715691	68444	79335	rs879255569	NC_000023.11:153715690:T:C
NC_000014.8:g.(?_54410919)_(55369403_?)del	BMP4|CDKN3|CGRRF1|CNIH1|GCH1|GMFB|SAMD4A		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Apr 10, 2022)	criteria provided, single submitter	VCV002422501	14	54410919 - 55369403			2422501	1942534		
NC_000023.10:g.100582860_100610076del	BTK|TIMM8A		Deafness dystonia syndrome	Pathogenic(Last reviewed: Nov 3, 2021)	no assertion criteria provided	VCV001312518	X	100582860 - 100610076			1312518	1302779		
NC_000023.10:g.100580141_100619992del	BTK|TIMM8A		Deafness dystonia syndrome	Pathogenic(Last reviewed: Nov 3, 2021)	no assertion criteria provided	VCV001312517	X	100580141 - 100619992			1312517	1302778		
NC_000023.10:g.100564340_100627836del	BTK|TIMM8A		Deafness dystonia syndrome	Pathogenic(Last reviewed: Nov 3, 2021)	no assertion criteria provided	VCV001312516	X	100564340 - 100627836			1312516	1302777		
NM_003919.3(SGCE):c.1208_1209del (p.Thr403fs)	CASD1|SGCE	T303fs, T312fs, T353fs, T362fs, T365fs, T374fs, T394fs, T403fs, T430fs, T439fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Dec 22, 2021)	criteria provided, single submitter	VCV002414229	7	94228131 - 94228132	7	94598819 - 94598820	2414229	1936862		NC_000007.14:94598818:TGTGTGT:TGTGT
NM_003919.3(SGCE):c.734_737del (p.Gln245fs)	CASD1|SGCE	Q204fs, Q216fs, Q281fs, Q154fs, Q245fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 22, 2022)	criteria provided, single submitter	VCV002136575	7	94232690 - 94232693	7	94603378 - 94603381	2136575	1868042		NC_000007.14:94603377:AATT:
NM_003919.3(SGCE):c.1151del (p.Leu384fs)	CASD1|SGCE	L346fs, L343fs, L420fs, L284fs, L375fs, L384fs, L411fs, L293fs, L334fs, L355fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Oct 2, 2022)	criteria provided, single submitter	VCV002136573	7	94228189	7	94598877	2136573	1868040		NC_000007.14:94598876:A:
NM_003919.3(SGCE):c.809G>A (p.Trp270Ter)	CASD1|SGCE	W229*, W270*, W179*, W241*, W306*	Myoclonic dystonia 11	Pathogenic(Last reviewed: Apr 8, 2022)	criteria provided, single submitter	VCV002123174	7	94232618	7	94603306	2123174	2181068		NC_000007.14:94603305:C:T
NM_003919.3(SGCE):c.391-1G>T	CASD1|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Feb 24, 2022)	criteria provided, single submitter	VCV002102830	7	94252710	7	94623398	2102830	2161890		NC_000007.14:94623397:C:A
NM_003919.3(SGCE):c.898_925del (p.Glu300fs)	CASD1|SGCE	E300fs, E336fs, E271fs, E209fs, E259fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Jan 6, 2022)	criteria provided, single submitter	VCV002076487	7	94230070 - 94230097	7	94600758 - 94600785	2076487	2138290		NC_000007.14:94600757:TCAAAGAATCAGAAGGGGGTTTGTATTCTC:TC
NM_003919.3(SGCE):c.825+1G>T	CASD1|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Oct 10, 2022)	criteria provided, single submitter	VCV002034998	7	94232601	7	94603289	2034998	2100656		NC_000007.14:94603288:C:A
NM_003919.3(SGCE):c.774_775del (p.Cys258_Asp259delinsTer)	CASD1|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: May 26, 2022)	criteria provided, single submitter	VCV001999175	7	94232652 - 94232653	7	94603340 - 94603341	1999175	2060968		NC_000007.14:94603339:CACA:CA
NM_003919.3(SGCE):c.272T>G (p.Leu91Ter)	CASD1|SGCE	L127*, L50*, L62*, L91*	Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 9, 2022)	criteria provided, single submitter	VCV001804051	7	94257632	7	94628320	1804051	1861076		NC_000007.14:94628319:A:C
NM_003919.3(SGCE):c.703dup (p.Cys235fs)	CASD1|SGCE	C144fs, C194fs, C206fs, C235fs, C271fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Jun 25, 2021)	criteria provided, single submitter	VCV001804049	7	94232723 - 94232724	7	94603411 - 94603412	1804049	1861074		NC_000007.14:94603411:AA:AAA
NM_003919.3(SGCE):c.778A>T (p.Lys260Ter)	CASD1|SGCE	K169*, K219*, K231*, K260*, K296*	Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 4, 2022)	criteria provided, single submitter	VCV001804048	7	94232649	7	94603337	1804048	1861073		NC_000007.14:94603336:T:A
NM_003919.3(SGCE):c.898_899del (p.Glu300fs)	CASD1|SGCE	E209fs, E259fs, E271fs, E300fs, E336fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Jan 18, 2022)	criteria provided, single submitter	VCV001804047	7	94230096 - 94230097	7	94600784 - 94600785	1804047	1861072		NC_000007.14:94600783:TCTC:TC
NM_003919.3(SGCE):c.946del (p.Asp316fs)	CASD1|SGCE	D225fs, D275fs, D287fs, D316fs, D352fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Oct 13, 2021)	criteria provided, single submitter	VCV001709683	7	94230049	7	94600737	1709683	1708037		NC_000007.14:94600736:CC:C
NM_003919.3(SGCE):c.483del (p.Ala162fs)	CASD1|SGCE	A121fs, A133fs, A162fs, A198fs, A71fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Jul 12, 2022)	criteria provided, single submitter	VCV001709648	7	94248249	7	94618937	1709648	1708002		NC_000007.14:94618936:TT:T
NM_003919.3(SGCE):c.723_724dup (p.Pro242fs)	CASD1|SGCE	P151fs, P201fs, P213fs, P242fs, P278fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001686179	7	94232702 - 94232703	7	94603390 - 94603391	1686179	1678189		NC_000007.14:94603390:GA:GAGA
NM_003919.3(SGCE):c.658del (p.Glu220fs)	CASD1|SGCE	E179fs, E256fs, E220fs, E129fs, E191fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 23, 2021)	criteria provided, single submitter	VCV001459921	7	94248074	7	94618762	1459921	1481278		NC_000007.14:94618761:CC:C
NM_003919.3(SGCE):c.191_197dup (p.Tyr66Ter)	CASD1|SGCE	Y66*, Y102*, Y37*	Myoclonic dystonia 11	Pathogenic(Last reviewed: Apr 18, 2021)	criteria provided, single submitter	VCV001456373	7	94259065 - 94259066	7	94629753 - 94629754	1456373	1458312		NC_000007.14:94629753:TATTCTCT:TATTCTCTATTCTCT
NM_003919.3(SGCE):c.344A>G (p.Tyr115Cys)	CASD1|SGCE	Y151C, Y115C, Y74C, Y86C, Y24C	Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001454493	7	94257560	7	94628248	1454493	1444833		NC_000007.14:94628247:T:C
NM_003919.3(SGCE):c.571_572del (p.Trp191fs)	CASD1|SGCE	W162fs, W227fs, W100fs, W150fs, W191fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Nov 21, 2021)	criteria provided, single submitter	VCV001454373	7	94248160 - 94248161	7	94618848 - 94618849	1454373	1366978		NC_000007.14:94618847:CACACA:CACA
NM_003919.3(SGCE):c.663-2A>T	CASD1|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV001454062	7	94232766	7	94603454	1454062	1366670		NC_000007.14:94603453:T:A
NM_003919.3(SGCE):c.813C>A (p.Cys271Ter)	CASD1|SGCE	C242*, C180*, C271*, C230*, C307*	Myoclonic dystonia 11	Pathogenic(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001451845	7	94232614	7	94603302	1451845	1426244		NC_000007.14:94603301:G:T
NM_003919.3(SGCE):c.448_452del (p.Ile150fs)	CASD1|SGCE	I109fs, I121fs, I186fs, I59fs, I150fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001451375	7	94252648 - 94252652	7	94623336 - 94623340	1451375	1429629		NC_000007.14:94623335:ATTATATTA:ATTA
NM_003919.3(SGCE):c.903C>A (p.Tyr301Ter)	CASD1|SGCE	Y260*, Y301*, Y210*, Y272*, Y337*	Myoclonic dystonia 11	Pathogenic(Last reviewed: Oct 7, 2022)	criteria provided, single submitter	VCV001451374	7	94230092	7	94600780	1451374	1429628		NC_000007.14:94600779:G:T
NM_003919.3(SGCE):c.904_908dup (p.Pro304fs)	CASD1|SGCE	P275fs, P263fs, P213fs, P304fs, P340fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Mar 19, 2021)	criteria provided, single submitter	VCV001449245	7	94230086 - 94230087	7	94600774 - 94600775	1449245	1339000		NC_000007.14:94600774:GGTTTG:GGTTTGGTTTG
NM_003919.3(SGCE):c.895G>T (p.Gly299Ter)	CASD1|SGCE	G299*, G208*, G258*, G270*, G335*	Myoclonic dystonia 11	Pathogenic(Last reviewed: Sep 26, 2021)	criteria provided, single submitter	VCV001446049	7	94230100	7	94600788	1446049	1390879		NC_000007.14:94600787:C:A
NM_003919.3(SGCE):c.704_707del (p.Cys235fs)	CASD1|SGCE	C144fs, C235fs, C271fs, C194fs, C206fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Apr 21, 2022)	criteria provided, single submitter	VCV001442309	7	94232720 - 94232723	7	94603408 - 94603411	1442309	1475174		NC_000007.14:94603407:AAACAA:AA
NM_003919.3(SGCE):c.580del (p.Glu194fs)	CASD1|SGCE	E165fs, E153fs, E194fs, E103fs, E230fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Jul 12, 2021)	criteria provided, single submitter	VCV001440019	7	94248152	7	94618840	1440019	1368469		NC_000007.14:94618839:C:
NM_003919.3(SGCE):c.942C>G (p.Tyr314Ter)	CASD1|SGCE	Y223*, Y350*, Y273*, Y314*, Y285*	Myoclonic dystonia 11	Pathogenic(Last reviewed: Feb 22, 2022)	criteria provided, single submitter	VCV001429282	7	94230053	7	94600741	1429282	1454399		NC_000007.14:94600740:G:C
NM_003919.3(SGCE):c.463+2T>A	CASD1|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, single submitter	VCV001426795	7	94252635	7	94623323	1426795	1366468		NC_000007.14:94623322:A:T
NM_003919.3(SGCE):c.193_194del (p.Glu65fs)	CASD1|SGCE	E101fs, E36fs, E65fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Mar 18, 2022)	criteria provided, single submitter	VCV001420908	7	94259069 - 94259070	7	94629757 - 94629758	1420908	1399636		NC_000007.14:94629756:TCTCT:TCT
NM_003919.3(SGCE):c.153C>G (p.Tyr51Ter)	CASD1|SGCE	Y22*, Y51*, Y87*	Myoclonic dystonia 11	Pathogenic(Last reviewed: Mar 9, 2021)	criteria provided, single submitter	VCV001404117	7	94259110	7	94629798	1404117	1479816		NC_000007.14:94629797:G:C
NM_003919.3(SGCE):c.865_866insGCAGGAAGTGA (p.Ile289delinsSerArgLysTer)	CASD1|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001403187	7	94230129 - 94230130	7	94600817 - 94600818	1403187	1392799		NC_000007.14:94600817:TCACTTCCTG:TCACTTCCTGCTCACTTCCTG
NM_003919.3(SGCE):c.321del (p.Pro108fs)	CASD1|SGCE	P17fs, P67fs, P108fs, P79fs, P144fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Jul 12, 2022)	criteria provided, single submitter	VCV001351337	7	94257583	7	94628271	1351337	1407687		NC_000007.14:94628270:T:
NM_003919.3(SGCE):c.391-1G>A	CASD1|SGCE		not provided|Myoclonic dystonia 11	Pathogenic(Last reviewed: Oct 28, 2022)	criteria provided, multiple submitters, no conflicts	VCV001342071	7	94252710	7	94623398	1342071	1333469		NC_000007.14:94623397:C:T
NM_003919.3(SGCE):c.521del (p.Met174fs)	CASD1|SGCE	M133fs, M145fs, M174fs, M210fs, M83fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Dec 7, 2021)	criteria provided, single submitter	VCV001329499	7	94248211	7	94618899	1329499	1320185		NC_000007.14:94618898:A:
NM_003919.3(SGCE):c.751G>T (p.Glu251Ter)	CASD1|SGCE	E160*, E210*, E222*, E251*, E287*	not provided|Myoclonic dystonia 11	Pathogenic(Last reviewed: May 24, 2022)	criteria provided, multiple submitters, no conflicts	VCV001321115	7	94232676	7	94603364	1321115	1311359		NC_000007.14:94603363:C:A
NM_003919.3(SGCE):c.850del (p.Thr284fs)	CASD1|SGCE	T193fs, T243fs, T255fs, T284fs, T320fs	not provided|Myoclonic dystonia 11	Pathogenic/Likely pathogenic(Last reviewed: May 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV001213596	7	94230145	7	94600833	1213596	1203590		NC_000007.14:94600832:T:
NM_003919.3(SGCE):c.662G>T (p.Gly221Val)	CASD1|SGCE	G130V, G180V, G192V, G221V, G257V	Myoclonic dystonia 11	Pathogenic	no assertion criteria provided	VCV001172914	7	94248070	7	94618758	1172914	1162097		NC_000007.14:94618757:C:A
NM_003919.3(SGCE):c.604dup (p.Thr202fs)	CASD1|SGCE	T111fs, T161fs, T173fs, T202fs, T238fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV001074768	7	94248127 - 94248128	7	94618815 - 94618816	1074768	1061167		NC_000007.14:94618815:T:TT
NM_003919.3(SGCE):c.623_650del (p.Gly208fs)	CASD1|SGCE	G117fs, G167fs, G179fs, G208fs, G244fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV001070683	7	94248082 - 94248109	7	94618770 - 94618797	1070683	1061166		NC_000007.14:94618769:TCATTAATGGGAAGTGGCACCCTGCCAC:
NM_003919.3(SGCE):c.942C>A (p.Tyr314Ter)	CASD1|SGCE	Y223*, Y273*, Y285*, Y314*, Y350*	Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 29, 2021)	criteria provided, single submitter	VCV001069378	7	94230053	7	94600741	1069378	1061165		NC_000007.14:94600740:G:T
NM_003919.3(SGCE):c.1011del (p.Ala336_Tyr337insTer)	CASD1|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Apr 29, 2021)	no assertion criteria provided	VCV001065199	7	94229984	7	94600672	1065199	1053513		NC_000007.14:94600671:A:
NM_003919.3(SGCE):c.129_130delinsT (p.Lys43fs)	CASD1|SGCE	K79fs, K14fs, K43fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000969300	7	94259133 - 94259134	7	94629821 - 94629822	969300	955263	rs1804394258	NC_000007.14:94629820:CC:A
NM_003919.3(SGCE):c.799del (p.Tyr267fs)	CASD1|SGCE	Y176fs, Y226fs, Y238fs, Y267fs, Y303fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000847151	7	94232628	7	94603316	847151	833990	rs1799563986	NC_000007.14:94603315:AAAA:AAA
NM_003919.3(SGCE):c.314A>G (p.Gln105Arg)	CASD1|SGCE	Q76R, Q141R, Q14R, Q105R, Q64R	Myoclonic dystonia 11	Pathogenic(Last reviewed: Nov 3, 2020)	criteria provided, single submitter	VCV000807492	7	94257590	7	94628278	807492	798594	rs1584692239	NC_000007.14:94628277:T:C
NM_003919.3(SGCE):c.812G>A (p.Cys271Tyr)	CASD1|SGCE	C271Y, C180Y, C242Y, C307Y, C230Y	not provided|Myoclonic dystonia 11	Pathogenic/Likely pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000807490	7	94232615	7	94603303	807490	796098	rs372686312	NC_000007.14:94603302:C:T
NM_003919.3(SGCE):c.463+1G>A	CASD1|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV000654935	7	94252636	7	94623324	654935	651737	rs1584663290	NC_000007.14:94623323:C:T
NM_003919.3(SGCE):c.610del (p.Ala204fs)	CASD1|SGCE	A113fs, A175fs, A240fs, A163fs, A204fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Nov 27, 2021)	criteria provided, single submitter	VCV000654222	7	94248122	7	94618810	654222	636482	rs1584637958	NC_000007.14:94618809:CC:C
NM_003919.3(SGCE):c.444_447del (p.Ile148_Asn149insTer)	CASD1|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: May 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000646818	7	94252653 - 94252656	7	94623341 - 94623344	646818	636483	rs1584663425	NC_000007.14:94623340:ATTAATTA:ATTA
NM_003919.3(SGCE):c.810G>A (p.Trp270Ter)	CASD1|SGCE	W270*, W179*, W306*, W229*, W241*	Myoclonic dystonia 11|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000624290	7	94232617	7	94603305	624290	612792	rs1562811414	NC_000007.14:94603304:C:T
NM_003919.3(SGCE):c.663del (p.Val222fs)	CASD1|SGCE	V222fs, V131fs, V181fs, V193fs, V258fs	not provided|Myoclonic dystonia 11	Pathogenic(Last reviewed: Dec 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000586565	7	94232764	7	94603452	586565	577023	rs1562812370	NC_000007.14:94603451:G:
NC_000007.14:g.(?_94628182)_(94628379_?)del	CASD1|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000583692	7	94257494 - 94257691	7	94628182 - 94628379	583692	561162		
NM_003919.3(SGCE):c.841C>T (p.Gln281Ter)	CASD1|SGCE	Q281*, Q240*, Q252*, Q190*, Q317*	Myoclonic dystonia 11	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000575722	7	94230154	7	94600842	575722	567285	rs1562806242	NC_000007.14:94600841:G:A
NM_003919.3(SGCE):c.559del (p.Ala186_Val187insTer)	CASD1|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000532792	7	94248173	7	94618861	532792	523403	rs1554352906	NC_000007.14:94618860:C:
NM_003919.3(SGCE):c.795del (p.Gln265fs)	CASD1|SGCE	Q236fs, Q224fs, Q174fs, Q265fs, Q301fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000532791	7	94232632	7	94603320	532791	523500	rs1554345077	NC_000007.14:94603319:TT:T
NM_003919.3(SGCE):c.727C>T (p.Gln243Ter)	CASD1|SGCE	Q243*, Q202*, Q214*, Q279*, Q152*	Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000532790	7	94232700	7	94603388	532790	523505	rs1554345170	NC_000007.14:94603387:G:A
NM_003919.3(SGCE):c.733C>T (p.Gln245Ter)	CASD1|SGCE	Q245*, Q154*, Q281*, Q204*, Q216*	Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000532786	7	94232694	7	94603382	532786	523501	rs1554345162	NC_000007.14:94603381:G:A
NM_003919.3(SGCE):c.300del (p.Trp100fs)	CASD1|SGCE	W136fs, W100fs, W9fs, W59fs, W71fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	VCV000532785	7	94257604	7	94628292	532785	522950	rs1554358727	NC_000007.14:94628291:CC:C
NM_003919.3(SGCE):c.549_552del (p.Phe183fs)	CASD1|SGCE	F183fs, F154fs, F142fs, F219fs, F92fs	not provided|Myoclonic dystonia 11	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000488594	7	94248180 - 94248183	7	94618868 - 94618871	488594	481462	rs1554352952	NC_000007.14:94618867:AAGAAAG:AAG
NM_003919.3(SGCE):c.825+1_825+2del	CASD1|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV000464161	7	94232600 - 94232601	7	94603288 - 94603289	464161	458100	rs1554345052	NC_000007.14:94603287:AC:
NM_003919.3(SGCE):c.470del (p.Pro157fs)	CASD1|SGCE	P128fs, P193fs, P116fs, P157fs, P66fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000464157	7	94248262	7	94618950	464157	457737	rs1554353106	NC_000007.14:94618949:GGG:GG
NM_003919.3(SGCE):c.619del (p.Arg207fs)	CASD1|SGCE	R116fs, R178fs, R166fs, R207fs, R243fs	Myoclonic dystonia 11|not provided	Pathogenic(Last reviewed: May 23, 2023)	criteria provided, multiple submitters, no conflicts	VCV000448358	7	94248113	7	94618801	448358	441163	rs1554352819	NC_000007.14:94618800:T:
NM_003919.3(SGCE):c.402C>A (p.Tyr134Ter)	CASD1|SGCE	Y134*, Y105*, Y170*, Y43*, Y93*	not provided|Myoclonic dystonia 11	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448357	7	94252698	7	94623386	448357	441164	rs1554355416	NC_000007.14:94623385:G:T
NM_003919.3(SGCE):c.551T>C (p.Leu184Pro)	CASD1|SGCE	L184P, L220P, L93P, L143P, L155P	not provided|Myoclonic dystonia 11	Pathogenic/Likely pathogenic(Last reviewed: Dec 2, 2022)	criteria provided, multiple submitters, no conflicts	VCV000420156	7	94248181	7	94618869	420156	407283	rs1064794321	NC_000007.14:94618868:A:G
NM_003919.3(SGCE):c.783dup (p.Phe262fs)	CASD1|SGCE	F171fs, F262fs, F298fs, F233fs, F221fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Jan 30, 2023)	criteria provided, multiple submitters, no conflicts	VCV000397531	7	94232643 - 94232644	7	94603331 - 94603332	397531	384418	rs1189469219	NC_000007.14:94603331:TTTTTT:TTTTTTT
NM_003919.3(SGCE):c.667del (p.Tyr223fs)	CASD1|SGCE	Y132fs, Y182fs, Y259fs, Y194fs, Y223fs	not provided|Myoclonic dystonia 11	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2023)	criteria provided, multiple submitters, no conflicts	VCV000374784	7	94232760	7	94603448	374784	361670	rs1057519246	NC_000007.14:94603447:AAA:AA
NM_003919.3(SGCE):c.232+1G>T	CASD1|SGCE		not provided|Myoclonic dystonia 11	Pathogenic/Likely pathogenic(Last reviewed: Mar 26, 2022)	criteria provided, multiple submitters, no conflicts	VCV000372800	7	94259030	7	94629718	372800	359695	rs1057517990	NC_000007.14:94629717:C:A
NM_003919.3(SGCE):c.1210_1213del (p.Asp404fs)	CASD1|SGCE	D395fs, D431fs, D354fs, D363fs, D404fs, D304fs, D313fs, D366fs, D375fs, D440fs	not provided|Myoclonic dystonia 11	Pathogenic/Likely pathogenic(Last reviewed: Mar 8, 2022)	criteria provided, multiple submitters, no conflicts	VCV000265518	7	94228127 - 94228130	7	94598815 - 94598818	265518	259887	rs886039595	NC_000007.14:94598814:TGTCTGT:TGT
NM_003919.3(SGCE):c.771_772del (p.Thr257_Cys258insTer)	CASD1|SGCE		not provided|Myoclonic dystonia 11	Pathogenic(Last reviewed: Sep 12, 2023)	criteria provided, multiple submitters, no conflicts	VCV000198162	7	94232655 - 94232656	7	94603343 - 94603344	198162	195323	rs794727794	NC_000007.14:94603342:AT:
NM_003919.3(SGCE):c.709C>T (p.Arg237Ter)	CASD1|SGCE	R237*, R146*, R273*, R196*, R208*	not provided|Myoclonic dystonia 11	Pathogenic(Last reviewed: Mar 14, 2022)	criteria provided, multiple submitters, no conflicts	VCV000094384	7	94232718	7	94603406	94384	100284	rs398123812	NC_000007.14:94603405:G:A
NM_003919.3(SGCE):c.619_620del (p.Arg207fs)	CASD1|SGCE	R166fs, R207fs, R116fs, R178fs, R243fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Nov 14, 2006)	no assertion criteria provided	VCV000005779	7	94248112 - 94248113	7	94618800 - 94618801	5779	20818	rs863223285	NC_000007.14:94618799:CT:
NM_003919.3(SGCE):c.663-6109_825+550del	CASD1|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000005778	7	94232052 - 94238873	7	94602740 - 94609561	5778	20817		
NM_003919.2(SGCE):c.464_662del	CASD1|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000005777	7	94233566 - 94248585	7	94604254 - 94619273	5777	20816		
NM_003919.3(SGCE):c.1114C>T (p.Arg372Ter)	CASD1|SGCE	R372*, R322*, R334*, R399*, R272*, R331*, R281*, R343*, R363*, R408*	not provided|Myoclonic dystonia 11	Pathogenic(Last reviewed: Apr 1, 2023)	criteria provided, multiple submitters, no conflicts	VCV000005776	7	94228226	7	94598914	5776	20815	rs121908492	NC_000007.14:94598913:G:A
NM_003919.3(SGCE):c.391-82_405del	CASD1|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Sep 1, 2001)	no assertion criteria provided	VCV000005771	7	94252695 - 94252791	7	94623383 - 94623479	5771	20810		
NM_003919.3(SGCE):c.304C>T (p.Arg102Ter)	CASD1|SGCE	R102*, R11*, R138*, R61*, R73*	not provided|Myoclonic dystonia 11	Pathogenic(Last reviewed: Oct 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000005769	7	94257600	7	94628288	5769	20808	rs121908490	NC_000007.14:94628287:G:A
NM_003919.3(SGCE):c.289C>T (p.Arg97Ter)	CASD1|SGCE	R97*, R68*, R56*, R6*, R133*	Inborn genetic diseases|not provided|Myoclonic dystonia 11	Pathogenic(Last reviewed: Oct 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000005768	7	94257615	7	94628303	5768	20807	rs121908489	NC_000007.14:94628302:G:A
NM_003690.5(PRKRA):c.638G>T (p.Cys213Phe)	CHROMR|PRKRA	C100F, C188F, C202F, C213F	Dystonia 16	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2023)	criteria provided, multiple submitters, no conflicts	VCV001686097	2	179301018	2	178436291	1686097	1678108		NC_000002.12:178436290:C:A
NM_003690.5(PRKRA):c.665C>T (p.Pro222Leu)	CHROMR|PRKRA	P222L, P211L, P109L, P197L	Dystonia 16|not provided	Pathogenic(Last reviewed: Feb 23, 2023)	criteria provided, multiple submitters, no conflicts	VCV000006346	2	179300991	2	178436264	6346	21385	rs121434410	NC_000002.12:178436263:G:A
NC_000005.9:g.(?_1253823)_(1448148_?)del	CLPTM1L|SLC6A3|TERT		Parkinsonism-dystonia, infantile	Pathogenic(Last reviewed: Jun 15, 2020)	criteria provided, single submitter	VCV001072228	5	1253823 - 1448148			1072228	1057123		
NM_004369.4(COL6A3):c.2506C>T (p.Arg836Ter)	COL6A3	R836*, R229*, R429*, R630*	not provided|Bethlem myopathy 1|Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|Dystonia 27	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000419449	2	238285979	2	237377336	419449	405672	rs761796175	NC_000002.12:237377335:G:A
NM_004369.4(COL6A3):c.8966-1G>C	COL6A3		Dystonia 27|not provided|Bethlem myopathy 1	Pathogenic(Last reviewed: Jun 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000192263	2	238243533	2	237334890	192263	190063	rs767517186	NC_000002.12:237334889:C:G
NM_203486.3(DLL3):c.599_603dup (p.Pro202fs)	DLL3|LOC130064417|PLEKHG2	P202fs	Leukodystrophy and acquired microcephaly with or without dystonia;|not provided|Spondylocostal dysostosis 1, autosomal recessive	Pathogenic(Last reviewed: Jul 4, 2023)	criteria provided, multiple submitters, no conflicts	VCV000006828	19	39993644 - 39993648	19	39502998 - 39502999	6828	21867	rs786200899	NC_000019.10:39502998:GCGGTGCGGT:GCGGTGCGGTGCGGT
NM_001135651.3(EIF2AK2):c.388G>A (p.Gly130Arg)	EIF2AK2	G130R	Dystonia 33	Pathogenic/Likely pathogenic(Last reviewed: Jun 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV001332908	2	37368697	2	37141554	1332908	1323638		NC_000002.12:37141553:C:T
NM_002016.2(FLG):c.544A>T (p.Lys182Ter)	FLG|FLG-AS1	K182*	Microcephaly|Congenital cerebellar hypoplasia|Ichthyosis|Abnormality of salivation|Paroxysmal dystonia|Feeding difficulties|Abnormality of the skin|Dry skin	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523448	1	152286818	1	152314342	523448	513892	rs1218912272	NC_000001.11:152314341:T:A
NM_000161.3(GCH1):c.544C>T (p.Gln182Ter)	GCH1	Q182*	Dystonia 5	Pathogenic(Last reviewed: Feb 23, 2023)	criteria provided, single submitter	VCV002444362	14	55312568	14	54845850	2444362	2418095		NC_000014.9:54845849:G:A
NC_000014.8:g.(?_55310735)_(55326474_?)del	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Dec 9, 2021)	criteria provided, single submitter	VCV002422499	14	55310735 - 55326474			2422499	1942532		
NM_000161.3(GCH1):c.233del (p.Ile78fs)	GCH1	I78fs	Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Feb 24, 2022)	criteria provided, single submitter	VCV002137592	14	55369149	14	54902431	2137592	1874711		NC_000014.9:54902430:A:
NM_000161.3(GCH1):c.626+2T>C	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: May 9, 2022)	criteria provided, single submitter	VCV002135851	14	55312484	14	54845766	2135851	2187279		NC_000014.9:54845765:A:G
NM_000161.3(GCH1):c.49del (p.Arg17fs)	GCH1|LOC130055692	R17fs	GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Aug 8, 2022)	criteria provided, single submitter	VCV002135615	14	55369333	14	54902615	2135615	2188870		NC_000014.9:54902614:T:
NM_000161.3(GCH1):c.185del (p.Glu62fs)	GCH1	E62fs	Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: May 8, 2022)	criteria provided, single submitter	VCV002135414	14	55369197	14	54902479	2135414	2188669		NC_000014.9:54902478:T:
NM_000161.3(GCH1):c.287G>A (p.Trp96Ter)	GCH1	W96*	Dystonia 5	Pathogenic(Last reviewed: May 13, 2022)	criteria provided, single submitter	VCV001803977	14	55369095	14	54902377	1803977	1861002		NC_000014.9:54902376:C:T
NM_000161.3(GCH1):c.510-1G>T	GCH1		Dystonia 5	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001685844	14	55313849	14	54847131	1685844	1677857		NC_000014.9:54847130:C:A
NM_000161.3(GCH1):c.601G>T (p.Gly201Ter)	GCH1	G201*	Dystonia 5	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001685843	14	55312511	14	54845793	1685843	1677856		NC_000014.9:54845792:C:A
NC_000014.8:g.(?_55369019)_(55369381_?)del	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Feb 9, 2022)	criteria provided, single submitter	VCV001460271	14	55369019 - 55369381			1460271	1493974		
NM_000161.3(GCH1):c.322G>A (p.Gly108Ser)	GCH1	G108S	Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, single submitter	VCV001457832	14	55369060	14	54902342	1457832	1471399		NC_000014.9:54902341:C:T
NM_000161.3(GCH1):c.395_396del (p.Val132fs)	GCH1	V132fs	Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Jan 8, 2021)	criteria provided, single submitter	VCV001457490	14	55332102 - 55332103	14	54865384 - 54865385	1457490	1393431		NC_000014.9:54865383:CACA:CA
NM_000161.3(GCH1):c.453+2T>G	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV001455907	14	55332043	14	54865325	1455907	1380167		NC_000014.9:54865324:A:C
NC_000014.8:g.(?_55310735)_(55313868_?)del	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Oct 6, 2021)	criteria provided, single submitter	VCV001454630	14	55310735 - 55313868			1454630	1444969		
NC_000014.8:g.(?_55312466)_(55313868_?)del	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Mar 3, 2022)	criteria provided, single submitter	VCV001454629	14	55312466 - 55313868			1454629	1444968		
NM_000161.3(GCH1):c.1A>C (p.Met1Leu)	GCH1|LOC130055692	M1L	Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Sep 20, 2021)	criteria provided, single submitter	VCV001452723	14	55369381	14	54902663	1452723	1431867		NC_000014.9:54902662:T:G
NM_000161.3(GCH1):c.212del (p.Leu71fs)	GCH1	L71fs	GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Oct 16, 2021)	criteria provided, single submitter	VCV001419261	14	55369170	14	54902452	1419261	1386940		NC_000014.9:54902451:A:
NM_000161.3(GCH1):c.109G>T (p.Glu37Ter)	GCH1|LOC130055692	E37*	GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Oct 30, 2022)	criteria provided, single submitter	VCV001354621	14	55369273	14	54902555	1354621	1434206		NC_000014.9:54902554:C:A
NM_000161.3(GCH1):c.728dup (p.Phe244fs)	GCH1	F244fs	Dystonia 5	Pathogenic(Last reviewed: Jan 7, 2022)	criteria provided, single submitter	VCV001334460	14	55310759 - 55310760	14	54844041 - 54844042	1334460	1325355		NC_000014.9:54844041:T:TT
NM_000161.3(GCH1):c.578_583del (p.Ile193_Glu195delinsLys)	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV001199011	14	55312529 - 55312534	14	54845811 - 54845816	1199011	1188131		NC_000014.9:54845810:CCGTGA:
NM_000161.3(GCH1):c.158G>A (p.Trp53Ter)	GCH1	W53*	GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV001070688	14	55369224	14	54902506	1070688	1063113		NC_000014.9:54902505:C:T
NC_000014.8:g.(?_55332039)_(55369387_?)del	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001070263	14	55332039 - 55369387			1070263	1057655		
NC_000014.8:g.(?_55313807)_(55313858_?)del	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001070262	14	55313807 - 55313858			1070262	1057654		
NM_000161.3(GCH1):c.626+2dup	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000996113	14	55312483 - 55312484	14	54845765 - 54845766	996113	983819	rs1474519447	NC_000014.9:54845765:A:AA
NM_000161.3(GCH1):c.250G>T (p.Glu84Ter)	GCH1	E84*	GTP cyclohydrolase I deficiency|Dystonia 5|Dystonia 5	Pathogenic(Last reviewed: May 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000958404	14	55369132	14	54902414	958404	948589	rs755556239	NC_000014.9:54902413:C:A
NM_000161.3(GCH1):c.454-2A>G	GCH1		not provided	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000871220	14	55326456	14	54859738	871220	860111	rs2039866854	NC_000014.9:54859737:T:C
NM_000161.3(GCH1):c.473del (p.Pro158fs)	GCH1	P158fs	GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000848233	14	55326435	14	54859717	848233	841560	rs2039866628	NC_000014.9:54859716:GG:G
NC_000014.9:g.(?_54859671)_(54865446_?)del	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000832851	14	55326389 - 55332164			832851	820629		
NC_000014.9:g.(?_54902311)_(54902702_?)del	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV000832331	14	55369029 - 55369420			832331	820630		
NM_000161.3(GCH1):c.646C>T (p.Arg216Ter)	GCH1	R216*	GTP cyclohydrolase I deficiency|not provided|Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: May 28, 2022)	criteria provided, multiple submitters, no conflicts	VCV000803028	14	55310842	14	54844124	803028	791413	rs41298440	NC_000014.9:54844123:G:A
NC_000014.9:g.(?_54865317)_(54865446_?)del	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000652965	14	55332035 - 55332164	14	54865317 - 54865446	652965	652318		
NM_000161.3(GCH1):c.76del (p.Asp26fs)	GCH1|LOC130055692	D26fs	GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV000647643	14	55369306	14	54902588	647643	642518	rs1595031674	NC_000014.9:54902587:CCC:CC
NM_000161.3(GCH1):c.1A>G (p.Met1Val)	GCH1|LOC130055692	M1V	GTP cyclohydrolase I deficiency|Dystonia 5|not provided	Pathogenic(Last reviewed: Mar 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000642685	14	55369381	14	54902663	642685	642519	rs1555362907	NC_000014.9:54902662:T:C
NM_000161.3(GCH1):c.127_130dup (p.Ala44fs)	GCH1	A44fs	Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000641586	14	55369251 - 55369252	14	54902533 - 54902534	641586	642517	rs1595031524	NC_000014.9:54902533:CCTC:CCTCCCTC
NM_000161.3(GCH1):c.509+1_509+3delinsTGTGAG	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000641360	14	55326396 - 55326398	14	54859678 - 54859680	641360	652355	rs1594982939	NC_000014.9:54859677:TAC:CTCACA
NM_000161.3(GCH1):c.248dup (p.Glu84fs)	GCH1	E84fs	Dystonia 5|GTP cyclohydrolase I deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000640887	14	55369133 - 55369134	14	54902415 - 54902416	640887	642515	rs1595031221	NC_000014.9:54902415:CCC:CCCC
NM_000161.3(GCH1):c.532A>T (p.Arg178Ter)	GCH1	R178*	Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Oct 4, 2018)	criteria provided, single submitter	VCV000640160	14	55313826	14	54847108	640160	642512	rs1594971274	NC_000014.9:54847107:T:A
NM_000161.3(GCH1):c.614T>A (p.Val205Glu)	GCH1	V205E	GTP cyclohydrolase I deficiency|GCH1-related condition|Dystonia 5|GTP cyclohydrolase I deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 7, 2023)	criteria provided, multiple submitters, no conflicts	VCV000574828	14	55312498	14	54845780	574828	566501	rs1418922853	NC_000014.9:54845779:A:T
NM_000161.3(GCH1):c.220_223del (p.Ala74fs)	GCH1	A74fs	Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: May 5, 2018)	criteria provided, single submitter	VCV000573159	14	55369159 - 55369162	14	54902441 - 54902444	573159	568949	rs1566687321	NC_000014.9:54902440:AGGC:
NC_000014.9:g.(?_54902301)_(54902683_?)del	GCH1|LOC130055692		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, single submitter	VCV000529416	14	55369019 - 55369401	14	54902301 - 54902683	529416	527839		
NM_000161.3(GCH1):c.626+1G>A	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000529415	14	55312485	14	54845767	529415	528574	rs1555358507	NC_000014.9:54845766:C:T
NM_000161.3(GCH1):c.186_197delinsA (p.Asp63fs)	GCH1	D63fs	GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000529414	14	55369185 - 55369196	14	54902467 - 54902478	529414	528685	rs1555362845	NC_000014.9:54902466:AGCTCGTTATCC:T
NM_000161.3(GCH1):c.344-1G>A	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV000529413	14	55332155	14	54865437	529413	528680	rs1555360050	NC_000014.9:54865436:C:T
NM_000161.3(GCH1):c.541+1G>T	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5|not provided	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000489338	14	55313816	14	54847098	489338	482050	rs1555358599	NC_000014.9:54847097:C:A
NM_000161.3(GCH1):c.541+1G>C	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000465762	14	55313816	14	54847098	465762	463824	rs1555358599	NC_000014.9:54847097:C:G
NM_000161.3(GCH1):c.344-1G>C	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000465761	14	55332155	14	54865437	465761	464169	rs1555360050	NC_000014.9:54865436:C:G
NM_000161.3(GCH1):c.278dup (p.Thr94fs)	GCH1	T94fs	GTP cyclohydrolase I deficiency|Dystonia 5|Dystonia 5	Pathogenic(Last reviewed: May 5, 2022)	criteria provided, single submitter	VCV000465759	14	55369103 - 55369104	14	54902385 - 54902386	465759	464175	rs1555362835	NC_000014.9:54902385:TT:TTT
NM_000161.3(GCH1):c.1A>T (p.Met1Leu)	GCH1|LOC130055692	M1L	GTP cyclohydrolase I deficiency|Dystonia 5|Dystonia 5	Pathogenic(Last reviewed: Feb 23, 2022)	criteria provided, single submitter	VCV000465758	14	55369381	14	54902663	465758	464177	rs1555362907	NC_000014.9:54902662:T:A
NC_000014.9:g.(?_54865307)_(54865456_?)del	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Feb 21, 2022)	criteria provided, single submitter	VCV000465757	14	55332025 - 55332174	14	54865307 - 54865456	465757	463966		
NM_000161.3(GCH1):c.626+1G>T	GCH1		Dystonia 5|GTP cyclohydrolase I deficiency|Dystonia 5|not provided	Pathogenic(Last reviewed: Jul 14, 2022)	criteria provided, multiple submitters, no conflicts	VCV000449485	14	55312485	14	54845767	449485	445238	rs1555358507	NC_000014.9:54845766:C:A
NM_000161.3(GCH1):c.607G>A (p.Gly203Arg)	GCH1	G203R	not provided|Dystonia 5|GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Sep 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000381665	14	55312505	14	54845787	381665	373875	rs988395114	NC_000014.9:54845786:C:T
NM_000161.3(GCH1):c.631_632del (p.Met211fs)	GCH1	M211fs	not provided|Inborn genetic diseases|Dystonia 5|GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Aug 22, 2023)	criteria provided, multiple submitters, no conflicts	VCV000265173	14	55310856 - 55310857	14	54844138 - 54844139	265173	260057	rs886039379	NC_000014.9:54844137:AT:
NM_000161.3(GCH1):c.595C>G (p.Pro199Ala)	GCH1	P199A	Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive	Pathogenic(Last reviewed: Jan 1, 2004)	no assertion criteria provided	VCV000009292	14	55312517	14	54845799	9292	24331	rs137852633	NC_000014.9:54845798:G:C
NC_000014.9:(?_54842017)_(54902826_?)del	GCH1		Dystonia 5	Pathogenic(Last reviewed: Jan 1, 2007)	no assertion criteria provided	VCV000009291					9291	24330		
NM_000161.3(GCH1):c.142C>T (p.Gln48Ter)	GCH1	Q48*	GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV000009288	14	55369240	14	54902522	9288	24327	rs104894444	NC_000014.9:54902521:G:A
NM_000161.3(GCH1):c.404T>A (p.Ile135Lys)	GCH1	I135K	Dystonia 5	Pathogenic(Last reviewed: Feb 25, 1999)	no assertion criteria provided	VCV000009285	14	55332094	14	54865376	9285	24324	rs104894441	NC_000014.9:54865375:A:T
NM_000161.3(GCH1):c.323G>A (p.Gly108Asp)	GCH1	G108D	GTP cyclohydrolase I deficiency|Dystonia 5|not provided	Pathogenic(Last reviewed: Mar 28, 2022)	criteria provided, multiple submitters, no conflicts	VCV000009282	14	55369059	14	54902341	9282	24321	rs104894435	NC_000014.9:54902340:C:T
NM_000161.3(GCH1):c.353del (p.Asn118fs)	GCH1	N118fs	Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive	Pathogenic(Last reviewed: Jul 1, 1998)	no assertion criteria provided	VCV000009280	14	55332145	14	54865427	9280	24319		NC_000014.9:54865426:TTT:TT
NM_000161.3(GCH1):c.453+1G>C	GCH1		GTP cyclohydrolase I deficiency|Dystonia 5	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV000009279	14	55332044	14	54865326	9279	24318		NC_000014.9:54865325:C:G
NM_000161.3(GCH1):c.431A>C (p.His144Pro)	GCH1	H144P	Dystonia 5	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000009278	14	55332067	14	54865349	9278	24317	rs104894440	NC_000014.9:54865348:T:G
NM_000161.3(GCH1):c.3G>C (p.Met1Ile)	GCH1|LOC130055692	M1I	Dystonia 5	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000009277	14	55369379	14	54902661	9277	24316	rs104894439	NC_000014.9:54902660:C:G
NM_000161.3(GCH1):c.344-2A>G	GCH1		Dystonia 5	Pathogenic(Last reviewed: Sep 1, 1997)	no assertion criteria provided	VCV000009275	14	55332156	14	54865438	9275	24314		NC_000014.9:54865437:T:C
NM_000161.3(GCH1):c.602G>A (p.Gly201Glu)	GCH1	G201E	Dystonia 5	Pathogenic(Last reviewed: Oct 1, 2000)	no assertion criteria provided	VCV000009274	14	55312510	14	54845792	9274	24313	rs104894438	NC_000014.9:54845791:C:T
NM_000161.3(GCH1):c.3_4dup (p.Glu2fs)	GCH1|LOC130055692	E2fs	Dystonia 5	Pathogenic(Last reviewed: Apr 28, 1995)	no assertion criteria provided	VCV000009273	14	55369377 - 55369378	14	54902659 - 54902660	9273	24312		NC_000014.9:54902659:CC:CCCC
NM_000161.3(GCH1):c.401A>T (p.Asp134Val)	GCH1	D134V	Dystonia 5	Pathogenic(Last reviewed: Apr 28, 1995)	no assertion criteria provided	VCV000009272	14	55332097	14	54865379	9272	24311	rs104894437	NC_000014.9:54865378:T:A
NM_000161.3(GCH1):c.262C>T (p.Arg88Trp)	GCH1	R88W	Dystonia 5	Pathogenic(Last reviewed: Apr 28, 1995)	no assertion criteria provided	VCV000009271	14	55369120	14	54902402	9271	24310	rs104894433	NC_000014.9:54902401:G:A
NM_182978.4(GNAL):c.964C>T (p.Arg322Ter)	GNAL	R245*, R322*, R38*	not provided	Pathogenic(Last reviewed: Apr 1, 2017)	criteria provided, single submitter	VCV000626333	18	11868595	18	11868596	626333	614664	rs1252185897	NC_000018.10:11868595:C:T
NM_001369387.1(GNAL):c.61C>T (p.Arg21Ter)	GNAL	R21*	Dystonia 25	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039972	18	11752493	18	11752494	39972	48492	rs398122928	NC_000018.10:11752493:C:T
NM_182978.4(GNAL):c.822dup (p.Arg275fs)	GNAL	R198fs, R275fs	Dystonia 25	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039971	18	11864575 - 11864576	18	11864576 - 11864577	39971	48491	rs398122927	NC_000018.10:11864576:A:AA
NM_182978.4(GNAL):c.514dup (p.Ser172fs)	GNAL	S95fs, S172fs	Dystonia 25	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039970	18	11753831 - 11753832	18	11753832 - 11753833	39970	48490	rs398122926	NC_000018.10:11753832:TTT:TTTT
NM_182978.4(GNAL):c.694G>A (p.Glu232Lys)	GNAL	E155K, E232K	Dystonia 25	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039969	18	11824986	18	11824987	39969	48489	rs398122925	NC_000018.10:11824986:G:A
NM_182978.4(GNAL):c.1109C>A (p.Ser370Ter)	GNAL	S293*, S370*, S86*	Dystonia 25	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000039968	18	11872344	18	11872345	39968	48488	rs398122924	NC_000018.10:11872344:C:A
NM_002143.3(HPCA):c.212C>A (p.Thr71Asn)	HPCA	T71N	Torsion dystonia 2	Pathogenic(Last reviewed: Apr 2, 2015)	no assertion criteria provided	VCV000190119	1	33354711	1	32889110	190119	187951	rs775863165	NC_000001.11:32889109:C:A
NM_002143.3(HPCA):c.225C>A (p.Asn75Lys)	HPCA	N75K	Torsion dystonia 2	Pathogenic(Last reviewed: Apr 2, 2015)	no assertion criteria provided	VCV000190118	1	33354724	1	32889123	190118	187950	rs786205675	NC_000001.11:32889122:C:A
NC_000011.9:g.(?_2181023)_(2193087_?)del	INS|INS-IGF2|TH		Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Sep 19, 2022)	criteria provided, single submitter	VCV001457228	11	2181023 - 2193087			1457228	1477963		
NM_021614.4(KCNN2):c.1748G>A (p.Gly583Glu)	KCNN2|LOC101927078	G23E, G583E, G649E	Dystonia 34, myoclonic	Pathogenic(Last reviewed: Jun 8, 2023)	no assertion criteria provided	VCV001338743	5	113798856	5	114463159	1338743	1329778		NC_000005.10:114463158:G:A
NM_172107.4(KCNQ2):c.1678C>T (p.Arg560Trp)	KCNQ2	R560W, R529W, R532W, R542W	Neurodevelopmental disorder|Developmental and epileptic encephalopathy, 7|Inborn genetic diseases|not provided|Early infantile epileptic encephalopathy with suppression bursts	Pathogenic/Likely pathogenic(Last reviewed: Dec 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000205915	20	62044888	20	63413535	205915	203726	rs773171451	NC_000020.11:63413534:G:A
NM_001282684.2(KCTD17):c.413G>A (p.Arg138His)	KCTD17	R145H, R138H	not provided	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000191372	22	37453460	22	37057420	191372	189177	rs786205860	NC_000022.11:37057419:G:A
NM_014727.3(KMT2B):c.5060dup (p.Asp1687fs)	KMT2B	D1687fs	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Aug 10, 2023)	no assertion criteria provided	VCV002577441	19	36221009 - 36221010	19	35730108 - 35730109	2577441	2742336		NC_000019.10:35730108:A:AA
NM_014727.3(KMT2B):c.7012del (p.Asp2338fs)	KMT2B	D2338fs	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Dec 17, 2020)	criteria provided, single submitter	VCV001803994	19	36224549	19	35733648	1803994	1861019		NC_000019.10:35733647:GG:G
NM_014727.3(KMT2B):c.5741_5748dup (p.Ser1917fs)	KMT2B	S1917fs	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Sep 27, 2022)	criteria provided, single submitter	VCV001708481	19	36223186 - 36223187	19	35732285 - 35732286	1708481	1706779		NC_000019.10:35732285:TCCCGTCGTCCC:TCCCGTCGTCCCGTCGTCCC
NM_014727.3(KMT2B):c.5230_5233del (p.Ser1744fs)	KMT2B	S1744fs	not provided|Dystonia 28, childhood-onset	Pathogenic(Last reviewed: May 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV001687549	19	36221467 - 36221470	19	35730566 - 35730569	1687549	1679842		NC_000019.10:35730565:TCTGTCTG:TCTG
NM_014727.3(KMT2B):c.683del (p.Ala228fs)	KMT2B	A228fs	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001685914	19	36210932	19	35720030	1685914	1677927		NC_000019.10:35720029:C:
NM_014727.3(KMT2B):c.5073C>T (p.Gly1691=)	KMT2B		Dystonia 28, childhood-onset	Pathogenic	criteria provided, single submitter	VCV001525972	19	36221023	19	35730122	1525972	1517316		NC_000019.10:35730121:C:T
NM_014727.3(KMT2B):c.6413dup (p.Ala2139fs)	KMT2B	A2139fs	Dystonia 28, childhood-onset|not provided	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001297015	19	36223857 - 36223858	19	35732956 - 35732957	1297015	1286805		NC_000019.10:35732956:CCCCCC:CCCCCCC
NM_014727.3(KMT2B):c.7614del (p.Thr2539fs)	KMT2B	T2539fs	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV001172540	19	36228599	19	35737698	1172540	1161651		NC_000019.10:35737697:CC:C
NM_014727.3(KMT2B):c.3596dup (p.Met1202fs)	KMT2B	M1202fs	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Apr 9, 2020)	no assertion criteria provided	VCV000988727	19	36216183 - 36216184	19	35725282 - 35725283	988727	976672		NC_000019.10:35725282:GGGGG:GGGGGG
NM_014727.3(KMT2B):c.3335-9_3363del	KMT2B		Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV000976707	19	36215529 - 36215566	19	35724628 - 35724665	976707	964891	rs1969359289	NC_000019.10:35724627:CCTGCCTAGAGCTGCCACTGCCAGAACCTGAGGAGCAG:
NM_014727.3(KMT2B):c.118del (p.Ala40fs)	KMT2B	A40fs	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000870575	19	36209035	19	35718133	870575	858745	rs1969024891	NC_000019.10:35718132:GGGG:GGG
NM_014727.3(KMT2B):c.648_649insA (p.Arg217fs)	KMT2B	R217fs	not provided	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000817932	19	36210897 - 36210898	19	35719995 - 35719996	817932	806040	rs1599668553	NC_000019.10:35719995::A
NM_014727.3(KMT2B):c.15_24dup (p.Ser9fs)	KMT2B	S9fs	not provided|Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Mar 22, 2022)	criteria provided, multiple submitters, no conflicts	VCV000817423	19	36208925 - 36208926	19	35718023 - 35718024	817423	806039	rs1599665134	NC_000019.10:35718023:GGCGGCGGCGGGCGGCGGC:GGCGGCGGCGGGCGGCGGCGGGCGGCGGC
NM_014727.3(KMT2B):c.6517_6518insA (p.Arg2173fs)	KMT2B	R2173fs	Generalized dystonia|Dysarthria	Pathogenic	no assertion criteria provided	VCV000813004	19	36223967 - 36223968	19	35733066 - 35733067	813004	801192	rs1599695744	NC_000019.10:35733066::A
NM_014727.3(KMT2B):c.4549C>T (p.Arg1517Ter)	KMT2B	R1517*	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000807438	19	36219050	19	35728149	807438	798749	rs1459799356	NC_000019.10:35728148:C:T
NM_014727.3(KMT2B):c.424C>T (p.Arg142Ter)	KMT2B	R142*	Dystonia 28, childhood-onset|Global developmental delay	Pathogenic(Last reviewed: Nov 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000807435	19	36210431	19	35719529	807435	798746	rs748888652	NC_000019.10:35719528:C:T
NM_014727.3(KMT2B):c.521dup (p.Thr176fs)	KMT2B	T176fs	Dystonia 28, childhood-onset|not provided	Pathogenic(Last reviewed: Jun 23, 2023)	criteria provided, multiple submitters, no conflicts	VCV000488539	19	36210763 - 36210764	19	35719861 - 35719862	488539	481407	rs763183959	NC_000019.10:35719861:CCCCCCC:CCCCCCCC
NM_014727.3(KMT2B):c.12_24dup (p.Ser9fs)	KMT2B	S9fs	Inborn genetic diseases|Dystonia 28, childhood-onset|not provided	Pathogenic(Last reviewed: Aug 1, 2023)	criteria provided, multiple submitters, no conflicts	VCV000450816	19	36208922 - 36208923	19	35718020 - 35718021	450816	446086	rs1555727493	NC_000019.10:35718020:GGCGGCGGCGGCGGGCGGCGGC:GGCGGCGGCGGCGGGCGGCGGCGGCGGGCGGCGGC
NM_014727.3(KMT2B):c.1690C>T (p.Arg564Ter)	KMT2B	R564*	Dystonia 28, childhood-onset	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000374875	19	36211939	19	35721037	374875	361780	rs1057519283	NC_000019.10:35721036:C:T
NM_014727.3(KMT2B):c.402dup (p.Ser135fs)	KMT2B	S135fs	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Feb 1, 2017)	no assertion criteria provided	VCV000374874	19	36210404 - 36210405	19	35719502 - 35719503	374874	361779	rs1057519282	NC_000019.10:35719502:CCCCC:CCCCCC
NM_014727.3(KMT2B):c.7050-2A>G	KMT2B		Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000374872	19	36224662	19	35733761	374872	361777	rs1057519280	NC_000019.10:35733760:A:G
NM_014727.3(KMT2B):c.1633C>T (p.Arg545Ter)	KMT2B	R545*	Dystonia 28, childhood-onset	Pathogenic/Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000374871	19	36211882	19	35720980	374871	361776	rs1057519279	NC_000019.10:35720979:C:T
NM_014727.3(KMT2B):c.6406del (p.Leu2136fs)	KMT2B	L2136fs	Dystonia 28, childhood-onset	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000374870	19	36223856	19	35732955	374870	361775	rs1057519278	NC_000019.10:35732954:C:
nsv1067840	LOC129388752|SLC30A10		Hypermanganesemia with dystonia, polycythemia, and cirrhosis	Pathogenic(Last reviewed: Aug 30, 2012)	no assertion criteria provided	VCV000038295	1	219990803 - 220091941	1	219817461 - 219918599	38295	46862		
NM_003124.5(SPR):c.-13G>A	LOC129934069|SPR		Dopa-responsive dystonia due to sepiapterin reductase deficiency	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000012942	2	73114549	2	72887420	12942	27981	rs750423023	NC_000002.12:72887419:G:A
NM_015488.5(PNKD):c.26C>T (p.Ala9Val)	LOC129935594|PNKD	A9V	Paroxysmal nonkinesigenic dyskinesia|not provided|Paroxysmal nonkinesigenic dyskinesia 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 22, 2023)	criteria provided, multiple submitters, no conflicts	VCV000001892	2	219135284	2	218270561	1892	16931	rs121434511	NC_000002.12:218270560:C:T
NM_003900.5(SQSTM1):c.175dup (p.Arg59fs)	LOC129995449|SQSTM1	R59fs	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	Pathogenic(Last reviewed: Jun 10, 2020)	no assertion criteria provided	VCV000984628	5	179248110 - 179248111	5	179821110 - 179821111	984628	972717	rs1757757569	NC_000005.10:179821110:C:CC
NC_000007.14:g.(?_94395012)_(94656118_?)del	LOC129998824|LOC129998825|LOC129998822|LOC129998823|CASD1|COL1A2|SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV000532801	7	94024324 - 94285430	7	94395012 - 94656118	532801	522658		
NM_021729.6(VPS11):c.136C>T (p.Pro46Ser)	LOC130006887|VPS11	P46S	Dystonia 32	Pathogenic(Last reviewed: Nov 30, 2021)	no assertion criteria provided	VCV001326862	11	118938670	11	119067959	1326862	1317310		NC_000011.10:119067958:C:T
NM_006087.4(TUBB4A):c.4C>G (p.Arg2Gly)	LOC130063295|TUBB4A	R2G, R53G, R47G	Torsion dystonia 4	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000050984	19	6502220	19	6502209	50984	65655	rs587776983	NC_000019.10:6502208:G:C
NM_016011.5(MECR):c.910G>T (p.Asp304Tyr)	MECR	D304Y, D228Y, D254Y, D332Y, D339Y	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	Pathogenic(Last reviewed: Jun 23, 2021)	no assertion criteria provided	VCV001173961	1	29522507	1	29195995	1173961	1163060		NC_000001.11:29195994:C:A
NC_000001.11:g.29203234del	MECR		Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000807442	1	29529743	1	29203231	807442	798471	rs1574315873	NC_000001.11:29203230:CCCC:CCC
NM_016011.5(MECR):c.830+2dup	MECR		Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities|not provided|Mitochondrial disease	Pathogenic/Likely pathogenic(Last reviewed: Mar 3, 2023)	criteria provided, multiple submitters, no conflicts	VCV000449055	1	29527026	1	29200513 - 29200514	449055	442819	rs756421370	NC_000001.11:29200513:A:AA
NM_016011.5(MECR):c.247_250del (p.Asn83fs)	MECR	N111fs, N33fs, N83fs, N118fs, N7fs	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	Pathogenic	criteria provided, single submitter	VCV000374883	1	29543124 - 29543127	1	29216612 - 29216615	374883	361788	rs1057519287	NC_000001.11:29216611:GATTGAT:GAT
NM_016011.4(MECR):c.772C>T (p.Arg258Trp)	MECR	R258W, R182W, R286W, R208W, R293W	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities|not provided	Pathogenic(Last reviewed: Jun 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000374882	1	29527086	1	29200574	374882	361787	rs145192716	NC_000001.11:29200573:G:A
NM_016011.5(MECR):c.854A>G (p.Tyr285Cys)	MECR	Y285C, Y235C, Y209C, Y313C, Y320C	Childhood Onset Dystonias|Optic atrophy|Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	Pathogenic/Likely pathogenic(Last reviewed: Jan 7, 2017)	no assertion criteria provided	VCV000374881	1	29522747	1	29196235	374881	361786	rs759218713	NC_000001.11:29196234:T:C
NM_016011.5(MECR):c.855T>G (p.Tyr285Ter)	MECR	Y285*, Y235*, Y209*, Y313*, Y320*	not provided	Pathogenic(Last reviewed: Aug 1, 2023)	criteria provided, multiple submitters, no conflicts	VCV000374879	1	29522746	1	29196234	374879	361784	rs1057519286	NC_000001.11:29196233:A:C
NM_016011.5(MECR):c.695G>A (p.Gly232Glu)	MECR	G232E, G156E, G267E, G182E, G260E	Mitochondrial disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 3, 2023)	criteria provided, multiple submitters, no conflicts	VCV000374878	1	29528516	1	29202004	374878	361783	rs762913101	NC_000001.11:29202003:C:T
m.10197G>A	MT-ND3		Mitochondrial disease	Pathogenic(Last reviewed: Jul 25, 2022)	reviewed by expert panel	VCV000009715	MT	10197	MT	10197	9715	24754	rs267606891	NC_012920.1:10196:G:A
m.14487T>C	MT-ND6		Mitochondrial disease	Pathogenic(Last reviewed: Aug 8, 2022)	reviewed by expert panel	VCV000009694	MT	14487	MT	14487	9694	24733	rs199476109	NC_012920.1:14486:T:C
m.14596A>T	MT-ND6		Leber optic atrophy and dystonia	Pathogenic(Last reviewed: Apr 1, 1996)	no assertion criteria provided	VCV000009690	MT	14596	MT	14596	9690	24729	rs387906424	NC_012920.1:14595:A:T
m.14459G>A	MT-ND6		Mitochondrial disease	Pathogenic(Last reviewed: Nov 1, 2021)	reviewed by expert panel	VCV000009689	MT	14459	MT	14459	9689	24728	rs199476105	NC_012920.1:14458:G:A
m.5816A>G	MT-TC		Dystonia, mitochondrial	Pathogenic(Last reviewed: Aug 28, 2007)	no assertion criteria provided	VCV000030002	MT	5816	MT	5816	30002	38957	rs387906732	NC_012920.1:5815:A:G
NM_006186.4(NR4A2):c.591_592del (p.Leu198fs)	NR4A2	L135fs, L198fs	Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism	Pathogenic(Last reviewed: Aug 21, 2023)	criteria provided, single submitter	VCV002576541	2	157186107 - 157186108	2	156329595 - 156329596	2576541	2741438		NC_000002.12:156329594:GGGG:GG
NM_006186.4(NR4A2):c.698del (p.Pro233fs)	NR4A2	P170fs, P233fs	Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism	Pathogenic(Last reviewed: Jul 12, 2022)	criteria provided, single submitter	VCV001710386	2	157186001	2	156329489	1710386	1708796		NC_000002.12:156329488:GGG:GG
NM_006186.4(NR4A2):c.956G>A (p.Arg319Gln)	NR4A2	R256Q	Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism	Pathogenic(Last reviewed: Sep 8, 2022)	no assertion criteria provided	VCV001693498	2	157184954	2	156328442	1693498	1685932		NC_000002.12:156328441:C:T
NM_006186.4(NR4A2):c.914G>A (p.Cys305Tyr)	NR4A2	C242Y	Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism	Pathogenic(Last reviewed: Jun 22, 2022)	no assertion criteria provided	VCV001693496	2	157184996	2	156328484	1693496	1685930		NC_000002.12:156328483:C:T
NM_006186.4(NR4A2):c.839G>A (p.Cys280Tyr)	NR4A2	C280Y, C217Y	Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism	Pathogenic(Last reviewed: Jun 22, 2022)	no assertion criteria provided	VCV001693495	2	157185860	2	156329348	1693495	1685929		NC_000002.12:156329347:C:T
NM_006186.4(NR4A2):c.325dup (p.Gln109fs)	NR4A2	Q109fs, Q46fs	Neurodevelopmental disorder|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Nov 12, 2023)	criteria provided, multiple submitters, no conflicts	VCV000985332	2	157186373 - 157186374	2	156329861 - 156329862	985332	973244	rs774629025	NC_000002.12:156329861:GGGGGGG:GGGGGGGG
NM_017426.4(NUP54):c.[1414G>A;1420C>T]	NUP54	E424K, L426F	Dystonia 37, early-onset, with striatal lesions	Pathogenic(Last reviewed: Jun 26, 2023)	no assertion criteria provided	VCV002506594	4|4	77036629	4|4	76115476	2506594	2671566|2671567		NC_000004.12:76115475:C:T|NC_000004.12:76115469:G:A
NM_017426.4(NUP54):c.1404ACA[2] (p.Gln471del)	NUP54	Q423del, Q471del	Dystonia 37, early-onset, with striatal lesions	Pathogenic(Last reviewed: Jun 26, 2023)	no assertion criteria provided	VCV002506593	4	77036631 - 77036633	4	76115478 - 76115480	2506593	2671565		NC_000004.12:76115477:TGTTGTTGTT:TGTTGTT
NM_017426.4(NUP54):c.1126A>G (p.Lys376Glu)	NUP54	K376E, K328E	Dystonia 37, early-onset, with striatal lesions	Pathogenic(Last reviewed: Jun 26, 2023)	no assertion criteria provided	VCV002506592	4	77045840	4	76124687	2506592	2671564		NC_000004.12:76124686:T:C
NM_017426.4(NUP54):c.1073T>G (p.Ile358Ser)	NUP54	I358S, I310S	Dystonia 37, early-onset, with striatal lesions	Pathogenic(Last reviewed: Jun 26, 2023)	no assertion criteria provided	VCV002506591	4	77045893	4	76124740	2506591	2671563		NC_000004.12:76124739:A:C
NM_002599.5(PDE2A):c.1180C>T (p.Gln394Ter)	PDE2A	Q387*, Q394*, Q373*, Q385*	EEG abnormality|Intellectual disability, moderate|Generalized hypotonia|Chorea|Paroxysmal dystonia|Interictal EEG abnormality	Pathogenic	criteria provided, single submitter	VCV000689477	11	72297116	11	72586072	689477	677070	rs1591023585	NC_000011.10:72586071:G:A
NM_000287.4(PEX6):c.371T>C (p.Leu124Pro)	PEX6	L124P	Premature ovarian insufficiency|Paroxysmal dystonia|Cerebellar ataxia|Peripheral neuropathy|Sensorineural hearing impairment|Cognitive impairment	Pathogenic(Last reviewed: Oct 21, 2019)	no assertion criteria provided	VCV000869197	6	42946518	6	42978780	869197	857411	rs1770427781	NC_000006.12:42978779:A:G
NM_022835.3(PLEKHG2):c.610C>T (p.Arg204Trp)	PLEKHG2	R204W, R145W	PLEKHG2-related condition|Leukodystrophy and acquired microcephaly with or without dystonia;|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2023)	criteria provided, multiple submitters, no conflicts	VCV000522394	19	39907506	19	39416866	522394	513006	rs201201843	NC_000019.10:39416865:C:T
NM_003690.5(PRKRA):c.267_268del (p.His89fs)	PRKRA	H64fs, H78fs, H89fs	Dystonia 16	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000006347	2	179312281 - 179312282	2	178447554 - 178447555	6347	21386	rs730880307	NC_000002.12:178447553:TAT:T
NM_005859.5(PURA):c.640G>T (p.Glu214Ter)	PURA	E214*	PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome|Apnea|Generalized hypotonia|Limb dystonia	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000635405	5	139494406	5	140114821	635405	623231	rs1581036558	NC_000005.10:140114820:G:T
NC_000007.13:g.(?_94252617)_(94252729_?)del	SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV002424795	7	94252617 - 94252729			2424795	1949872		
NM_003919.3(SGCE):c.579del (p.Glu194fs)	SGCE|CASD1	E153fs, E165fs, E194fs, E230fs, E103fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Mar 24, 2022)	criteria provided, single submitter	VCV002116413	7	94248153	7	94618841	2116413	2165128		NC_000007.14:94618840:T:
NM_003919.3(SGCE):c.158C>A (p.Ser53Ter)	SGCE|CASD1	S53*, S24*, S89*	Myoclonic dystonia 11	Pathogenic(Last reviewed: Oct 20, 2022)	criteria provided, single submitter	VCV002036303	7	94259105	7	94629793	2036303	2090359		NC_000007.14:94629792:G:T
NC_000007.13:g.(?_94285282)_(94285410_?)del	SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Sep 15, 2021)	criteria provided, single submitter	VCV001459683	7	94285282 - 94285410			1459683	1484871		
NC_000007.13:g.(?_94232582)_(94232784_?)del	SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001459378	7	94232582 - 94232784			1459378	1406505		
NC_000007.13:g.(?_94257494)_(94285410_?)del	SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Feb 19, 2021)	criteria provided, single submitter	VCV001459087	7	94257494 - 94285410			1459087	1406216		
NC_000007.13:g.(?_94248050)_(94248288_?)del	SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, single submitter	VCV001459085	7	94248050 - 94248288			1459085	1406214		
NC_000007.13:g.(?_94248050)_(94252729_?)del	SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, single submitter	VCV001458211	7	94248050 - 94252729			1458211	1467926		
NM_003919.3(SGCE):c.495_498del (p.Phe165fs)	SGCE|CASD1	F165fs, F124fs, F136fs, F201fs, F74fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Apr 1, 2022)	criteria provided, single submitter	VCV001452174	7	94248234 - 94248237	7	94618922 - 94618925	1452174	1438931		NC_000007.14:94618921:AATGAA:AA
NM_003919.3(SGCE):c.802dup (p.Ile268fs)	SGCE|CASD1	I177fs, I227fs, I239fs, I268fs, I304fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Apr 11, 2021)	criteria provided, single submitter	VCV001325061	7	94232624 - 94232625	7	94603312 - 94603313	1325061	1315323		NC_000007.14:94603312:T:TT
NM_003919.3(SGCE):c.1296dup (p.Gly433fs)	SGCE|CASD1	G333fs, G342fs, G383fs, G392fs, G395fs, G404fs, G424fs, G433fs, G458fs, G460fs, G469fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV001323588	7	94218001 - 94218002	7	94588689 - 94588690	1323588	1313871		NC_000007.14:94588689:T:TT
NM_003919.3(SGCE):c.37_38insA (p.Cys13Ter)	SGCE	C13*	Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, single submitter	VCV001323587	7	94285373 - 94285374	7	94656061 - 94656062	1323587	1313870		NC_000007.14:94656061::T
NC_000007.13:g.(?_94228081)_(94232770_?)del	SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV001073072	7	94228081 - 94232770			1073072	1057305		
NC_000007.13:g.(?_94252627)_(94252719_?)del	SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Sep 21, 2020)	criteria provided, single submitter	VCV001073071	7	94252627 - 94252719			1073071	1057306		
NM_003919.3(SGCE):c.109+1G>A	SGCE		Myoclonic dystonia 11|not provided	Pathogenic(Last reviewed: May 11, 2023)	criteria provided, multiple submitters, no conflicts	VCV001069379	7	94285301	7	94655989	1069379	1061170		NC_000007.14:94655988:C:T
NM_003919.3(SGCE):c.109+2T>C	SGCE		Myoclonic dystonia 11	Pathogenic(Last reviewed: Oct 28, 2022)	criteria provided, single submitter	VCV001067508	7	94285300	7	94655988	1067508	1055694		NC_000007.14:94655987:A:G
NM_003919.3(SGCE):c.786del (p.Arg263fs)	SGCE|CASD1	R222fs, R299fs, R263fs, R172fs, R234fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV000813325	7	94232641	7	94603329	813325	801548	rs1584546238	NC_000007.14:94603328:AAA:AA
NM_003919.3(SGCE):c.793C>T (p.Gln265Ter)	SGCE|CASD1	Q265*, Q301*, Q174*, Q224*, Q236*	Myoclonic dystonia 11	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802337	7	94232634	7	94603322	802337	790764	rs1584546131	NC_000007.14:94603321:G:A
NC_000007.14:g.(?_94598775)_(94603452_?)del	SGCE|CASD1		Myoclonic dystonia 11	Pathogenic(Last reviewed: May 2, 2016)	criteria provided, single submitter	VCV000464148			7	94598775 - 94603452	464148	456169		
NM_003919.3(SGCE):c.974del (p.Ser325fs)	SGCE|CASD1	S296fs, S234fs, S284fs, S325fs, S361fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: May 13, 2003)	no assertion criteria provided	VCV000005775	7	94230021	7	94600709	5775	20814	rs1584531843	NC_000007.14:94600708:G:
NM_003919.3(SGCE):c.884dup (p.Leu295fs)	SGCE|CASD1	L295fs, L254fs, L331fs, L204fs, L266fs	Myoclonic dystonia 11	Pathogenic(Last reviewed: Jun 24, 2003)	no assertion criteria provided	VCV000005774	7	94230110 - 94230111	7	94600798 - 94600799	5774	20813	rs863223284	NC_000007.14:94600798:AAAA:AAAAA
NM_003919.3(SGCE):c.587T>G (p.Leu196Arg)	SGCE|CASD1	L196R, L105R, L155R, L232R, L167R	Myoclonic dystonia 11	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000005773	7	94248145	7	94618833	5773	20812	rs121908491	NC_000007.14:94618832:A:C
NM_003919.3(SGCE):c.835_839del (p.Thr279fs)	SGCE|CASD1	T238fs, T250fs, T279fs, T188fs, T315fs	not provided|Myoclonic dystonia 11	Pathogenic/Likely pathogenic(Last reviewed: Aug 19, 2022)	criteria provided, multiple submitters, no conflicts	VCV000005772	7	94230156 - 94230160	7	94600844 - 94600848	5772	20811	rs863223283	NC_000007.14:94600843:TTTGTTTT:TTT
NM_018130.3(SHQ1):c.874G>A (p.Glu292Lys)	SHQ1	E292K	Neurodevelopmental disorder with dystonia and seizures	Pathogenic(Last reviewed: Jun 23, 2022)	no assertion criteria provided	VCV001693527	3	72866389	3	72817238	1693527	1685961		NC_000003.12:72817237:C:T
NM_018130.3(SHQ1):c.523G>T (p.Asp175Tyr)	SHQ1	D175Y	Dystonia 35, childhood-onset	Pathogenic(Last reviewed: Jun 23, 2022)	no assertion criteria provided	VCV001693526	3	72881596	3	72832445	1693526	1685960		NC_000003.12:72832444:C:A
NM_018130.3(SHQ1):c.828_831del (p.Asp277fs)	SHQ1	D277fs	Neurodevelopmental disorder with dystonia and seizures	Pathogenic(Last reviewed: Aug 28, 2023)	criteria provided, single submitter	VCV001693525	3	72866432 - 72866435	3	72817281 - 72817284	1693525	1685959		NC_000003.12:72817280:ATCAATCAA:ATCAA
NM_003054.6(SLC18A2):c.1160C>T (p.Pro387Leu)	SLC18A2	P387L	Parkinsonism-dystonia, infantile, 2	Pathogenic(Last reviewed: Oct 11, 2018)	no assertion criteria provided	VCV000548130	10	119027221	10	117267710	548130	538616	rs1392638187	NC_000010.11:117267709:C:T
NM_006516.4(SLC2A1):c.1141del (p.Val381fs)	SLC2A1	V381fs	Dystonia 9	Pathogenic(Last reviewed: Feb 17, 2023)	criteria provided, single submitter	VCV002430183	1	43393413	1	42927742	2430183	2403686		NC_000001.11:42927741:C:
NM_006516.4(SLC2A1):c.1A>G (p.Met1Val)	SLC2A1|SLC2A1-DT	M1V	Dystonia 9|Encephalopathy due to GLUT1 deficiency	Pathogenic(Last reviewed: Nov 30, 2023)	criteria provided, multiple submitters, no conflicts	VCV001686206	1	43424322	1	42958651	1686206	1678215		NC_000001.11:42958650:T:C
NM_006516.4(SLC2A1):c.29del (p.Gly10fs)	SLC2A1	G10fs	Dystonia 9	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001686205	1	43408982	1	42943311	1686205	1678214		NC_000001.11:42943310:CCC:CC
NM_006516.4(SLC2A1):c.37dup (p.Met13fs)	SLC2A1	M13fs	Dystonia 9	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001686204	1	43408973 - 43408974	1	42943302 - 42943303	1686204	1678213		NC_000001.11:42943302:T:TT
NM_006516.4(SLC2A1):c.115-2A>C	SLC2A1		not provided|Dystonia 9|Encephalopathy due to GLUT1 deficiency	Pathogenic(Last reviewed: Apr 11, 2023)	criteria provided, multiple submitters, no conflicts	VCV001686203	1	43396879	1	42931208	1686203	1678212		NC_000001.11:42931207:T:G
NM_006516.4(SLC2A1):c.524G>T (p.Gly175Val)	SLC2A1	G175V	Dystonia 9	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001686202	1	43395699	1	42930028	1686202	1678211		NC_000001.11:42930027:C:A
NM_006516.4(SLC2A1):c.635del (p.Arg212fs)	SLC2A1	R212fs	Dystonia 9	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001686201	1	43395588	1	42929917	1686201	1678210		NC_000001.11:42929916:C:
NM_006516.4(SLC2A1):c.1135_1147del (p.Phe379fs)	SLC2A1	F379fs	Dystonia 9	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001686200	1	43393407 - 43393419	1	42927736 - 42927748	1686200	1678209		NC_000001.11:42927735:GACCCACTTCAAAGA:GA
NM_006516.4(SLC2A1):c.1206_1215dup (p.Val406fs)	SLC2A1	V406fs	Dystonia 9	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001686199	1	43393338 - 43393339	1	42927667 - 42927668	1686199	1678208		NC_000001.11:42927667:GGCAATGGCAG:GGCAATGGCAGGCAATGGCAG
NM_006516.4(SLC2A1):c.1287_1288del (p.Cys429fs)	SLC2A1	C429fs	Dystonia 9	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001686198	1	43392903 - 43392904	1	42927232 - 42927233	1686198	1678207		NC_000001.11:42927231:CACACA:CACA
NM_006516.4(SLC2A1):c.739G>T (p.Glu247Ter)	SLC2A1	E247*	Dystonia 9|Encephalopathy due to GLUT1 deficiency|not provided	Pathogenic(Last reviewed: Apr 11, 2023)	criteria provided, multiple submitters, no conflicts	VCV001335936	1	43395392	1	42929721	1335936	1326949		NC_000001.11:42929720:C:A
NM_006516.4(SLC2A1):c.1028dup (p.Met344fs)	SLC2A1	M344fs	Dystonia 9|Encephalopathy due to GLUT1 deficiency|Childhood onset GLUT1 deficiency syndrome 2|Hereditary cryohydrocytosis with reduced stomatin	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000973266	1	43394648 - 43394649	1	42928977 - 42928978	973266	961587	rs1643457017	NC_000001.11:42928977:CC:CCC
NM_006516.4(SLC2A1):c.101A>G (p.Asn34Ser)	SLC2A1	N34S	not provided|Encephalopathy due to GLUT1 deficiency|Hereditary cryohydrocytosis with reduced stomatin|Encephalopathy due to GLUT1 deficiency|Childhood onset GLUT1 deficiency syndrome 2|Dystonia 9|Epilepsy, idiopathic generalized, susceptibility to, 12|GLUT1 deficiency syndrome 1, autosomal recessive	Pathogenic(Last reviewed: Apr 11, 2023)	criteria provided, multiple submitters, no conflicts	VCV000662199	1	43408910	1	42943239	662199	627878	rs80359812	NC_000001.11:42943238:T:C
NM_006516.4(SLC2A1):c.161dup (p.Ser55fs)	SLC2A1	S55fs	Hereditary cryohydrocytosis with reduced stomatin|Dystonia 9|Epilepsy, idiopathic generalized, susceptibility to, 12|Encephalopathy due to GLUT1 deficiency|Childhood onset GLUT1 deficiency syndrome 2	Pathogenic	criteria provided, single submitter	VCV000619980	1	43396830 - 43396831	1	42931159 - 42931160	619980	611376		NC_000001.11:42931159:T:TT
NM_006516.4(SLC2A1):c.400G>A (p.Gly134Ser)	SLC2A1	G134S	not provided|GLUT1 deficiency syndrome 1, autosomal recessive|Paroxysmal dystonia|Encephalopathy due to GLUT1 deficiency	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2023)	criteria provided, multiple submitters, no conflicts	VCV000374181	1	43396413	1	42930742	374181	360813	rs1057518953	NC_000001.11:42930741:C:T
NM_006516.4(SLC2A1):c.19-2A>G	SLC2A1		not provided|Encephalopathy due to GLUT1 deficiency|Childhood onset GLUT1 deficiency syndrome 2|Epilepsy, idiopathic generalized, susceptibility to, 12|Dystonia 9|Hereditary cryohydrocytosis with reduced stomatin|Encephalopathy due to GLUT1 deficiency	Pathogenic(Last reviewed: Apr 11, 2023)	criteria provided, multiple submitters, no conflicts	VCV000207225	1	43408994	1	42943323	207225	201174	rs796053272	NC_000001.11:42943322:T:C
NM_006516.4(SLC2A1):c.1198C>T (p.Arg400Cys)	SLC2A1	R400C	GLUT1 deficiency syndrome 1, autosomal recessive|Encephalopathy due to GLUT1 deficiency|Dystonia 9|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 11, 2023)	criteria provided, multiple submitters, no conflicts	VCV000207212	1	43393356	1	42927685	207212	201132	rs796053263	NC_000001.11:42927684:G:A
NM_006516.4(SLC2A1):c.972G>A (p.Ser324=)	SLC2A1		not provided|Encephalopathy due to GLUT1 deficiency|Dystonia 9	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2023)	criteria provided, multiple submitters, no conflicts	VCV000207202	1	43394881	1	42929210	207202	201146	rs796053254	NC_000001.11:42929209:C:T
NM_006516.4(SLC2A1):c.988C>T (p.Arg330Ter)	SLC2A1	R330*	not provided|Childhood onset GLUT1 deficiency syndrome 2|GLUT1 deficiency syndrome 1, autosomal recessive|Inborn genetic diseases|Encephalopathy due to GLUT1 deficiency|Encephalopathy due to GLUT1 deficiency|Childhood onset GLUT1 deficiency syndrome 2|Dystonia 9|Hereditary cryohydrocytosis with reduced stomatin	Pathogenic(Last reviewed: Apr 11, 2023)	criteria provided, multiple submitters, no conflicts	VCV000207196	1	43394689	1	42929018	207196	201142		NC_000001.11:42929017:G:A
NM_006516.4(SLC2A1):c.667C>T (p.Arg223Trp)	SLC2A1	R223W	GLUT1 deficiency syndrome 1, autosomal recessive|Encephalopathy due to GLUT1 deficiency|Encephalopathy due to GLUT1 deficiency|Childhood onset GLUT1 deficiency syndrome 2|Epilepsy, idiopathic generalized, susceptibility to, 12|Dystonia 9|Hereditary cryohydrocytosis with reduced stomatin|not provided	Pathogenic(Last reviewed: Apr 11, 2023)	criteria provided, multiple submitters, no conflicts	VCV000207193	1	43395556	1	42929885	207193	201157	rs796053248	NC_000001.11:42929884:G:A
NM_006516.4(SLC2A1):c.997C>T (p.Arg333Trp)	SLC2A1	R333W	Hereditary cryohydrocytosis with reduced stomatin|Encephalopathy due to GLUT1 deficiency|Childhood onset GLUT1 deficiency syndrome 2|Epilepsy, idiopathic generalized, susceptibility to, 12|Dystonia 9|not provided|GLUT1 deficiency syndrome|Inborn genetic diseases|Dystonia 9|Encephalopathy due to GLUT1 deficiency|Childhood onset GLUT1 deficiency syndrome 2|GLUT1 deficiency syndrome 1, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Jul 7, 2023)	criteria provided, multiple submitters, no conflicts	VCV000198842	1	43394680	1	42929009	198842	196002	rs80359825	NC_000001.11:42929008:G:A
NM_006516.4(SLC2A1):c.1372C>T (p.Arg458Trp)	SLC2A1	R458W	Encephalopathy due to GLUT1 deficiency|Childhood onset GLUT1 deficiency syndrome 2|Dystonia 9|Epilepsy, idiopathic generalized, susceptibility to, 12|Hereditary cryohydrocytosis with reduced stomatin|not provided|GLUT1 deficiency syndrome 1, autosomal recessive|Encephalopathy due to GLUT1 deficiency	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2023)	criteria provided, multiple submitters, no conflicts	VCV000096708	1	43392819	1	42927148	96708	102597	rs13306758	NC_000001.11:42927147:G:A
NM_006516.4(SLC2A1):c.634C>T (p.Arg212Cys)	SLC2A1	R212C	not provided|Encephalopathy due to GLUT1 deficiency|GLUT1 deficiency syndrome 1, autosomal recessive	Pathogenic(Last reviewed: Apr 11, 2023)	criteria provided, multiple submitters, no conflicts	VCV000037300	1	43395589	1	42929918	37300	45874	rs387907312	NC_000001.11:42929917:G:A
NM_006516.4(SLC2A1):c.376C>T (p.Arg126Cys)	SLC2A1	R126C	Hereditary cryohydrocytosis with reduced stomatin|not provided|Encephalopathy due to GLUT1 deficiency|GLUT1 deficiency syndrome 1, autosomal recessive	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2023)	criteria provided, multiple submitters, no conflicts	VCV000016118	1	43396437	1	42930766	16118	31157	rs80359818	NC_000001.11:42930765:G:A
NM_006516.4(SLC2A1):c.940G>A (p.Gly314Ser)	SLC2A1	G314S	not provided|Dystonia 9|GLUT1 deficiency syndrome 1, autosomal recessive|Encephalopathy due to GLUT1 deficiency	Pathogenic(Last reviewed: May 1, 2023)	criteria provided, multiple submitters, no conflicts	VCV000016113	1	43394913	1	42929242	16113	31152	rs121909739	NC_000001.11:42929241:C:T
NM_018713.3(SLC30A10):c.1235del (p.Gln412fs)	SLC30A10	Q412fs, Q349fs	Hypermanganesemia with dystonia, polycythemia, and cirrhosis	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000030889	1	220089014	1	219915672	30889	39846	rs281860292	NC_000001.11:219915671:T:
NM_018713.3(SLC30A10):c.507del (p.Pro170fs)	SLC30A10	P170fs	Hypermanganesemia with dystonia, polycythemia, and cirrhosis	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000030888	1	220101276	1	219927934	30888	39845	rs281860287	NC_000001.11:219927933:CCCCCC:CCCCC
NM_018713.3(SLC30A10):c.585del (p.Thr196fs)	SLC30A10		not provided	Pathogenic(Last reviewed: Aug 9, 2016)	criteria provided, single submitter	VCV000030887	1	220101198	1	219927856	30887	39844	rs281860288	NC_000001.11:219927855:CCCCC:CCCC
NM_018713.3(SLC30A10):c.266T>C (p.Leu89Pro)	SLC30A10	L89P	Hypermanganesemia with dystonia, polycythemia, and cirrhosis	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000030886	1	220101517	1	219928175	30886	39843	rs281860284	NC_000001.11:219928174:A:G
NM_018713.3(SLC30A10):c.314_322del (p.Ala105_Pro107del)	SLC30A10		Hypermanganesemia with dystonia, polycythemia, and cirrhosis	Pathogenic(Last reviewed: Mar 9, 2012)	no assertion criteria provided	VCV000030885	1	220101461 - 220101469	1	219928119 - 219928127	30885	39842	rs281860285	NC_000001.11:219928118:CGGGCCGGGC:C
NM_001128431.4(SLC39A14):c.1336C>T (p.Pro446Ser)	SLC39A14	P446S, P456S	Hypermanganesemia with dystonia 2	Pathogenic(Last reviewed: Jan 18, 2022)	no assertion criteria provided	VCV001334419	8	22277068	8	22419555	1334419	1325313		NC_000008.11:22419554:C:T
NM_001128431.4(SLC39A14):c.1407C>G (p.Asn469Lys)	SLC39A14	N469K, N479K	Hypermanganesemia with dystonia 2	Pathogenic(Last reviewed: May 2, 2018)	no assertion criteria provided	VCV000242928	8	22277139	8	22419626	242928	244030	rs750281602	NC_000008.11:22419625:C:G
NM_001128431.4(SLC39A14):c.1147G>A (p.Gly383Arg)	SLC39A14	G383R, G393R	Hypermanganesemia with dystonia 2	Pathogenic(Last reviewed: May 2, 2018)	no assertion criteria provided	VCV000242927	8	22273793	8	22416280	242927	244029	rs879253766	NC_000008.11:22416279:G:A
NM_015359.6(SLC39A14):c.477_478del (p.Ser160fs)	SLC39A14	S160fs	Hypermanganesemia with dystonia 2	Pathogenic(Last reviewed: May 2, 2018)	no assertion criteria provided	VCV000242926	8	22267478 - 22267479	8	22409965 - 22409966	242926	244028	rs879253765	NC_000008.11:22409964:CA:
NM_001128431.4(SLC39A14):c.313G>T (p.Glu105Ter)	SLC39A14	E105*, E115*	Hypermanganesemia with dystonia 2	Pathogenic(Last reviewed: Jan 19, 2022)	no assertion criteria provided	VCV000242925	8	22265865	8	22408352	242925	244027	rs879253764	NC_000008.11:22408351:G:T
NM_001128431.4(SLC39A14):c.292T>G (p.Phe98Val)	SLC39A14	F98V, F108V	Hypermanganesemia with dystonia 2	Pathogenic(Last reviewed: May 2, 2018)	no assertion criteria provided	VCV000242924	8	22265844	8	22408331	242924	244026	rs879253763	NC_000008.11:22408330:T:G
NM_001044.5(SLC6A3):c.892del (p.Tyr297_Leu298insTer)	SLC6A3		Parkinsonism-dystonia, infantile	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000939537	5	1420719	5	1420604	939537	932753	rs1756409749	NC_000005.10:1420603:GG:G
NM_003124.5(SPR):c.544C>T (p.Gln182Ter)	SPR	Q182*	Dopa-responsive dystonia due to sepiapterin reductase deficiency	Pathogenic(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV001323647	2	73115682	2	72888553	1323647	1313928		NC_000002.12:72888552:C:T
NM_003124.5(SPR):c.304+2_304+13del	SPR		Dopa-responsive dystonia due to sepiapterin reductase deficiency	Pathogenic(Last reviewed: May 27, 2021)	criteria provided, single submitter	VCV001162322	2	73114863 - 73114874	2	72887734 - 72887745	1162322	1151324		NC_000002.12:72887733:CGGGTAAGACCCCGGG:CGGG
NM_003124.4(SPR):c.596del	SPR		Dopa-responsive dystonia due to sepiapterin reductase deficiency	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000522878	2	73118475	2	72891346	522878	513525	rs1553498582	NC_000002.12:72891345:GG:G
NM_003124.5(SPR):c.655C>T (p.Arg219Ter)	SPR	R219*	Dopa-responsive dystonia due to sepiapterin reductase deficiency|not provided	Pathogenic(Last reviewed: Jun 8, 2023)	criteria provided, multiple submitters, no conflicts	VCV000235551	2	73118535	2	72891406	235551	237232	rs779204655	NC_000002.12:72891405:C:T
NM_003124.5(SPR):c.596-2A>G	SPR		Dopa-responsive dystonia due to sepiapterin reductase deficiency	Pathogenic(Last reviewed: Apr 13, 2015)	no assertion criteria provided	VCV000039869	2	73118474	2	72891345	39869	48468	rs398122922	NC_000002.12:72891344:A:G
NM_003124.5(SPR):c.304G>T (p.Gly102Cys)	SPR	G102C	Dopa-responsive dystonia due to sepiapterin reductase deficiency	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000031917	2	73114865	2	72887736	31917	40573	rs387907200	NC_000002.12:72887735:G:T
NM_003124.5(SPR):c.751A>T (p.Lys251Ter)	SPR	K251*	Dystonic disorder|not provided|Dopa-responsive dystonia due to sepiapterin reductase deficiency	Pathogenic(Last reviewed: Sep 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000012944	2	73118631	2	72891502	12944	27983	rs121917747	NC_000002.12:72891501:A:T
NM_003124.5(SPR):c.488C>T (p.Pro163Leu)	SPR	P163L	Dopa-responsive dystonia due to sepiapterin reductase deficiency	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000012943	2	73115626	2	72888497	12943	27982	rs104893666	NC_000002.12:72888496:C:T
NM_003124.5(SPR):c.448A>G (p.Arg150Gly)	SPR	R150G	Dystonic disorder|not provided|Dopa-responsive dystonia due to sepiapterin reductase deficiency	Pathogenic(Last reviewed: May 11, 2023)	criteria provided, multiple submitters, no conflicts	VCV000012941	2	73115586	2	72888457	12941	27980	rs104893665	NC_000002.12:72888456:A:G
NM_003124.5(SPR):c.448_452del (p.Thr151fs)	SPR	T151fs	Dopa-responsive dystonia due to sepiapterin reductase deficiency	Pathogenic(Last reviewed: Apr 1, 2012)	no assertion criteria provided	VCV000012940	2	73115583 - 73115587	2	72888454 - 72888458	12940	27979	rs587776777	NC_000002.12:72888453:AACAGAAC:AAC
NM_003124.5(SPR):c.355C>T (p.Gln119Ter)	SPR	Q119*	Dopa-responsive dystonia due to sepiapterin reductase deficiency	Pathogenic(Last reviewed: Aug 1, 2001)	no assertion criteria provided	VCV000012939	2	73115493	2	72888364	12939	27978	rs121917746	NC_000002.12:72888363:C:T
NM_003900.5(SQSTM1):c.1135_1138del (p.Glu379fs)	SQSTM1	E379fs, E295fs	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	Pathogenic	criteria provided, single submitter	VCV001704477	5	179260748 - 179260751	5	179833748 - 179833751	1704477	1699011		NC_000005.10:179833747:GAAGGAAG:GAAG
NM_003900.5(SQSTM1):c.784_820del (p.Gly262fs)	SQSTM1	G178fs, G262fs	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	Pathogenic(Last reviewed: May 2, 2022)	no assertion criteria provided	VCV001691078	5	179260061 - 179260097	5	179833061 - 179833097	1691078	1683486		NC_000005.10:179833060:GGAGGGAAAAGAAGCCGCCTGACCCCCGTCTCTCCAG:
NM_003900.4:c.875_876insT	SQSTM1		Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	Pathogenic(Last reviewed: Jan 25, 2022)	no assertion criteria provided	VCV001334785					1334785	1325708		
NM_003900.5(SQSTM1):c.934_936delinsTGA (p.Arg312Ter)	SQSTM1	R312*, R228*	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	Pathogenic(Last reviewed: Apr 7, 2022)	no assertion criteria provided	VCV001334784	5	179260211 - 179260213	5	179833211 - 179833213	1334784	1325707		NC_000005.10:179833210:AGG:TGA
NM_003900.5(SQSTM1):c.301+2T>A	SQSTM1		Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	Pathogenic(Last reviewed: Jan 25, 2022)	no assertion criteria provided	VCV001334783	5	179250055	5	179823055	1334783	1325706		NC_000005.10:179823054:T:A
NM_003900.5(SQSTM1):c.286C>T (p.Arg96Ter)	SQSTM1	R96*, R12*	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 1|Paget disease of bone 2, early-onset	Pathogenic(Last reviewed: Jan 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000265782	5	179250038	5	179823038	265782	260472	rs886039782	NC_000005.10:179823037:C:T
NM_003900.5(SQSTM1):c.311_312del (p.Glu104fs)	SQSTM1	E104fs, E20fs	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	Pathogenic(Last reviewed: May 2, 2023)	criteria provided, single submitter	VCV000265781	5	179250865 - 179250866	5	179823865 - 179823866	265781	260471	rs886039781	NC_000005.10:179823864:AGAG:AG
NM_003900.5(SQSTM1):c.2T>A (p.Met1Lys)	SQSTM1	M1K	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	Pathogenic(Last reviewed: Oct 10, 2016)	no assertion criteria provided	VCV000265780	5	179247938	5	179820938	265780	260470	rs886039780	NC_000005.10:179820937:T:A
NR_104387.1(TAF1):n.5894C>T	TAF1		X-linked dystonia-parkinsonism	Pathogenic(Last reviewed: Oct 18, 2012)	no assertion criteria provided	VCV000021011	X	70749635	X	71529785	21011	33863	rs397509359	NC_000023.11:71529784:C:T
TAF1, SVA RETROTRANSPOSON INSERTION	TAF1		X-linked dystonia-parkinsonism	Pathogenic(Last reviewed: Mar 1, 2007)	no assertion criteria provided	VCV000009862					9862	24901		
NM_001199107.2(TBC1D24):c.642_793del (p.Trp215fs)	TBC1D24	W215fs	Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome|Developmental and epileptic encephalopathy, 16|DOORS syndrome|Familial infantile myoclonic epilepsy|Developmental and epileptic encephalopathy, 1|Caused by mutation in the TBC1 domain family, member 24|Autosomal dominant nonsyndromic hearing loss 65	Pathogenic(Last reviewed: Aug 14, 2022)	criteria provided, multiple submitters, no conflicts	VCV001071941	16	2546786 - 2546937	16	2496785 - 2496936	1071941	1063616		
NM_001199107.2(TBC1D24):c.1501G>A (p.Gly501Arg)	TBC1D24	G501R, G495R	Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome	Pathogenic(Last reviewed: Aug 9, 2019)	no assertion criteria provided	VCV000652618	16	2550467	16	2500466	652618	653803	rs1596973014	NC_000016.10:2500465:G:A
NM_001199107.2(TBC1D24):c.1360_1363dup (p.Pro455fs)	TBC1D24	P455fs, P449fs	Developmental and epileptic encephalopathy, 1|Autosomal dominant nonsyndromic hearing loss 65|Caused by mutation in the TBC1 domain family, member 24|not provided|DOORS syndrome|Developmental and epileptic encephalopathy, 16|Autosomal dominant nonsyndromic hearing loss 65|Familial infantile myoclonic epilepsy|Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome|Autosomal recessive nonsyndromic hearing loss 86	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000421795	16	2550324 - 2550325	16	2500323 - 2500324	421795	409582	rs1292551263	NC_000016.10:2500323:CAAGC:CAAGCAAGC
NM_001199107.2(TBC1D24):c.1499C>T (p.Ala500Val)	TBC1D24	A500V, A494V	not provided|Developmental and epileptic encephalopathy, 1|Autosomal dominant nonsyndromic hearing loss 65|Caused by mutation in the TBC1 domain family, member 24|Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2022)	criteria provided, multiple submitters, no conflicts	VCV000419296	16	2550465	16	2500464	419296	409583	rs564477999	NC_000016.10:2500463:C:T
NC_000011.9:g.(?_2187222)_(2188272_?)del	TH		Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: May 27, 2022)	criteria provided, single submitter	VCV002427668	11	2187222 - 2188272			2427668	1951917		
NC_000011.9:g.(?_2186878)_(2193016_?)del	TH		Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Aug 7, 2022)	criteria provided, single submitter	VCV002427667	11	2186878 - 2193016			2427667	1951916		
NM_000360.4(TH):c.412C>T (p.Arg138Ter)	TH	R169*, R138*, R165*	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Feb 1, 2022)	criteria provided, single submitter	VCV002194153	11	2189796	11	2168566	2194153	1926353		NC_000011.10:2168565:G:A
NM_000360.4(TH):c.739_743dup (p.Cys248fs)	TH	C248fs, C275fs, C279fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Sep 23, 2022)	criteria provided, single submitter	VCV002114831	11	2188214 - 2188215	11	2166984 - 2166985	2114831	2164834		NC_000011.10:2166984:CAGGC:CAGGCCAGGC
NM_000360.4(TH):c.263del (p.Pro88fs)	TH	P115fs, P119fs, P88fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Mar 1, 2022)	criteria provided, single submitter	VCV002105184	11	2190929	11	2169699	2105184	2169536		NC_000011.10:2169698:GGGG:GGG
NM_000360.4(TH):c.51del (p.Val18fs)	TH	V18fs	Autosomal recessive DOPA responsive dystonia	Pathogenic/Likely pathogenic(Last reviewed: Feb 20, 2022)	criteria provided, multiple submitters, no conflicts	VCV002100741	11	2192966	11	2171736	2100741	2154756		NC_000011.10:2171735:GG:G
NM_000360.4(TH):c.138dup (p.Lys47fs)	TH	K78fs, K47fs, K74fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Feb 4, 2022)	criteria provided, single submitter	VCV002093216	11	2191053 - 2191054	11	2169823 - 2169824	2093216	2156298		NC_000011.10:2169823:G:GG
NM_000360.4(TH):c.1252dup (p.Ala418fs)	TH	A449fs, A418fs, A445fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Dec 22, 2021)	criteria provided, single submitter	VCV002052457	11	2186543 - 2186544	11	2165313 - 2165314	2052457	2115504		NC_000011.10:2165313:CC:CCC
NM_000360.4(TH):c.1341T>A (p.Tyr447Ter)	TH	Y447*, Y474*, Y478*	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Dec 11, 2021)	criteria provided, single submitter	VCV002039753	11	2185616	11	2164386	2039753	2091215		NC_000011.10:2164385:A:T
NM_000360.4(TH):c.778del (p.Arg260fs)	TH	R291fs, R260fs, R287fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Sep 28, 2022)	criteria provided, single submitter	VCV002033133	11	2188180	11	2166950	2033133	2079494		NC_000011.10:2166949:G:
NM_000360.4(TH):c.837del (p.Lys280fs)	TH	K280fs, K307fs, K311fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Aug 21, 2022)	criteria provided, single submitter	VCV002025524	11	2188121	11	2166891	2025524	2080872		NC_000011.10:2166890:C:
NM_000360.4(TH):c.982_991del (p.Cys328fs)	TH	C355fs, C359fs, C328fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Jul 23, 2022)	criteria provided, single submitter	VCV002019062	11	2187766 - 2187775	11	2166536 - 2166545	2019062	2065434		NC_000011.10:2166535:CGTGGCAGCA:
NM_000360.4(TH):c.91-833dup	TH	T53fs, T57fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Jun 2, 2022)	criteria provided, single submitter	VCV001998536	11	2191933 - 2191934	11	2170703 - 2170704	1998536	2050457		NC_000011.10:2170703:T:TT
NM_000360.4(TH):c.507del (p.Val170fs)	TH	V170fs, V197fs, V201fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: May 3, 2022)	criteria provided, single submitter	VCV001947375	11	2189390	11	2168160	1947375	2006231		NC_000011.10:2168159:TTTT:TTT
NC_000011.9:g.(?_2187460)_(2191953_?)del	TH		Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Oct 10, 2022)	criteria provided, single submitter	VCV001460233	11	2187460 - 2191953			1460233	1481589		
NC_000011.9:g.(?_2191910)_(2193087_?)del	TH		Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Jan 5, 2021)	criteria provided, single submitter	VCV001458504	11	2191910 - 2193087			1458504	1468215		
NM_000360.4(TH):c.584C>A (p.Ser195Ter)	TH	S195*, S222*, S226*	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, single submitter	VCV001457222	11	2189156	11	2167926	1457222	1477957		NC_000011.10:2167925:G:T
NM_000360.4(TH):c.1122_1123delinsTT (p.Glu375Ter)	TH	E402*, E406*, E375*	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Apr 17, 2021)	criteria provided, single submitter	VCV001456177	11	2186975 - 2186976	11	2165745 - 2165746	1456177	1458117		NC_000011.10:2165744:CC:AA
NM_000360.4(TH):c.1125del (p.Glu375fs)	TH	E375fs, E402fs, E406fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Aug 11, 2021)	criteria provided, single submitter	VCV001455671	11	2186973	11	2165743	1455671	1379931		NC_000011.10:2165742:C:
NM_000360.4(TH):c.1189G>A (p.Gly397Arg)	TH	G424R, G397R, G428R	Autosomal recessive DOPA responsive dystonia	Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2022)	criteria provided, multiple submitters, no conflicts	VCV001452616	11	2186909	11	2165679	1452616	1364335		NC_000011.10:2165678:C:T
NM_000360.4(TH):c.374_387dup (p.Tyr130fs)	TH	Y157fs, Y130fs, Y161fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Mar 26, 2021)	criteria provided, single submitter	VCV001452491	11	2189820 - 2189821	11	2168590 - 2168591	1452491	1364211		NC_000011.10:2168590:CTCCAGGTGGGGGCC:CTCCAGGTGGGGGCCTCCAGGTGGGGGCC
NM_000360.4(TH):c.1210_1213del (p.Ser404fs)	TH	S431fs, S404fs, S435fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Aug 8, 2021)	criteria provided, single submitter	VCV001425111	11	2186583 - 2186586	11	2165353 - 2165356	1425111	1353618		NC_000011.10:2165352:CAGACAG:CAG
NM_000360.4(TH):c.1354C>T (p.Gln452Ter)	TH	Q452*, Q479*, Q483*	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, single submitter	VCV001390521	11	2185603	11	2164373	1390521	1396694		NC_000011.10:2164372:G:A
NM_000360.4(TH):c.281C>A (p.Ser94Ter)	TH	S121*, S125*, S94*	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Oct 20, 2021)	criteria provided, single submitter	VCV001371019	11	2190911	11	2169681	1371019	1427225		NC_000011.10:2169680:G:T
NM_000360.4(TH):c.1138A>T (p.Lys380Ter)	TH	K407*, K380*, K411*	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Apr 30, 2021)	criteria provided, single submitter	VCV001359133	11	2186960	11	2165730	1359133	1357410		NC_000011.10:2165729:T:A
NM_000360.4(TH):c.788del (p.Gly263fs)	TH	G263fs, G290fs, G294fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Sep 3, 2021)	criteria provided, single submitter	VCV001072805	11	2188170	11	2166940	1072805	1062297		NC_000011.10:2166939:CC:C
NM_000360.4(TH):c.1382C>T (p.Pro461Leu)	TH	P461L, P488L, P492L	Autosomal recessive DOPA responsive dystonia	Pathogenic/Likely pathogenic(Last reviewed: Sep 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV001004173	11	2185575	11	2164345	1004173	994423	rs767635052	NC_000011.10:2164344:G:A
NM_000360.4(TH):c.990del (p.His330fs)	TH	H330fs, H361fs, H357fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000969618	11	2187767	11	2166537	969618	956442	rs1846095407	NC_000011.10:2166536:G:
NM_000360.4(TH):c.646G>A (p.Gly216Ser)	TH	G243S, G247S, G216S	Autosomal recessive DOPA responsive dystonia|not provided|Dystonia 5	Pathogenic/Likely pathogenic(Last reviewed: Jul 17, 2023)	criteria provided, multiple submitters, no conflicts	VCV000948892	11	2188714	11	2167484	948892	926170	rs762304556	NC_000011.10:2167483:C:T
NM_000360.4(TH):c.78del (p.Glu27fs)	TH	E27fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Jul 25, 2019)	criteria provided, single submitter	VCV000946763	11	2192939	11	2171709	946763	926173	rs1846263622	NC_000011.10:2171708:T:
NM_000360.4(TH):c.991G>T (p.Glu331Ter)	TH	E331*, E362*, E358*	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000840013	11	2187766	11	2166536	840013	838191	rs1260079066	NC_000011.10:2166535:C:A
NM_000360.4(TH):c.1035_1045del (p.Gln346fs)	TH	Q346fs, Q377fs, Q373fs	Autosomal recessive DOPA responsive dystonia	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000639906	11	2187712 - 2187722	11	2166482 - 2166492	639906	639864	rs1590166832	NC_000011.10:2166481:GCGAGAACTGCGCGA:GCGA
NM_000360.4(TH):c.714_715del (p.Leu239fs)	TH	L270fs, L239fs, L266fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV000590824	11	2188243 - 2188244	11	2167013 - 2167014	590824	581766	rs1564918287	NC_000011.10:2167012:GCG:G
NM_199292.3(TH):c.-71C>T	TH		Autosomal recessive DOPA responsive dystonia	Pathogenic/Likely pathogenic(Last reviewed: Aug 9, 2023)	criteria provided, multiple submitters, no conflicts	VCV000558656	11	2193087	11	2171857	558656	546444	rs549435434	NC_000011.10:2171856:G:A
NM_000360.4(TH):c.850G>A (p.Gly284Ser)	TH	G315S, G284S, G311S	Autosomal recessive DOPA responsive dystonia	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2023)	criteria provided, multiple submitters, no conflicts	VCV000558576	11	2187990	11	2166760	558576	546631	rs1288483479	NC_000011.10:2166759:C:T
NM_000360.4(TH):c.203del (p.Leu68fs)	TH	L68fs, L95fs, L99fs	Autosomal recessive DOPA responsive dystonia	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2023)	criteria provided, multiple submitters, no conflicts	VCV000557613	11	2190989	11	2169759	557613	546278	rs1554923852	NC_000011.10:2169758:A:
NM_000360.4(TH):c.1176_1180del (p.Ser394fs)	TH	S394fs, S421fs, S425fs	Autosomal recessive DOPA responsive dystonia	Pathogenic/Likely pathogenic(Last reviewed: May 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000557508	11	2186918 - 2186922	11	2165688 - 2165692	557508	545998	rs1554922593	NC_000011.10:2165687:ACAGCA:A
NM_199292.2(TH):c.-70G>A	TH		Autosomal recessive DOPA responsive dystonia|not provided	Pathogenic(Last reviewed: Feb 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000526213	11	2193086	11	2171856	526213	526534	rs1372180906	NC_000011.10:2171855:C:T
NM_000360.4(TH):c.672C>G (p.Tyr224Ter)	TH	Y224*, Y255*, Y251*	Inborn genetic diseases|Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000521707	11	2188688	11	2167458	521707	511908	rs1554923218	NC_000011.10:2167457:G:C
NM_000360.4(TH):c.364C>T (p.Arg122Ter)	TH	R153*, R122*, R149*	not provided|Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Sep 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000449110	11	2189844	11	2168614	449110	444773	rs771610752	NC_000011.10:2168613:G:A
NM_000360.4(TH):c.1103C>T (p.Thr368Met)	TH	T399M, T368M, T395M	Autosomal recessive DOPA responsive dystonia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 6, 2022)	criteria provided, multiple submitters, no conflicts	VCV000378729	11	2187233	11	2166003	378729	371332	rs1057520384	NC_000011.10:2166002:G:A
NM_000360.4(TH):c.292C>T (p.Arg98Ter)	TH	R129*, R98*, R125*	not provided|Autosomal recessive DOPA responsive dystonia	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2022)	criteria provided, multiple submitters, no conflicts	VCV000374732	11	2190900	11	2169670	374732	361618	rs1057519220	NC_000011.10:2169669:G:A
NM_000360.4(TH):c.601C>T (p.Gln201Ter)	TH	Q201*, Q232*, Q228*	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Jul 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000371630	11	2189139	11	2167909	371630	357968	rs1057517423	NC_000011.10:2167908:G:A
NM_000360.4(TH):c.12dup (p.Asp5fs)	TH	D5fs	Autosomal recessive DOPA responsive dystonia	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000370720	11	2193004 - 2193005	11	2171774 - 2171775	370720	357971	rs1057516716	NC_000011.10:2171774:GGGGG:GGGGGG
NM_000360.4(TH):c.283del (p.Ala95fs)	TH	A95fs, A122fs, A126fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Aug 28, 2014)	criteria provided, single submitter	VCV000208620	11	2190909	11	2169679	208620	205167	rs797045111	NC_000011.10:2169678:CC:C
NM_000360.4(TH):c.1282C>T (p.Gln428Ter)	TH	Q428*, Q459*, Q455*	Autosomal recessive DOPA responsive dystonia	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000188890	11	2186514	11	2165284	188890	186821	rs786204540	NC_000011.10:2165283:G:A
NM_000360.4(TH):c.202del (p.Leu68fs)	TH	L68fs, L99fs, L95fs	Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Jun 1, 1999)	no assertion criteria provided	VCV000012332	11	2190990	11	2169760	12332	27371		NC_000011.10:2169759:GGGGG:GGGG
NM_000360.4(TH):c.1105-24T>A	TH		Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Sep 1, 2000)	no assertion criteria provided	VCV000012331	11	2187017	11	2165787	12331	27370	rs587776767	NC_000011.10:2165786:A:T
NM_000360.4(TH):c.605G>A (p.Arg202His)	TH	R233H, R229H	not provided|Autosomal recessive DOPA responsive dystonia	Pathogenic(Last reviewed: Oct 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000012327	11	2189135	11	2167905	12327	27366	rs80338892	NC_000011.10:2167904:C:T
NM_000360.4(TH):c.614T>C (p.Leu205Pro)	TH	L236P, L205P, L232P	not provided|Autosomal recessive DOPA responsive dystonia	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2022)	criteria provided, multiple submitters, no conflicts	VCV000012325	11	2189126	11	2167896	12325	27364	rs121917763	NC_000011.10:2167895:A:G
NM_000360.4(TH):c.1141C>A (p.Gln381Lys)	TH	Q412K, Q381K, Q408K	Dystonic disorder|Autosomal recessive DOPA responsive dystonia	Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2022)	criteria provided, single submitter	VCV000012324	11	2186957	11	2165727	12324	27363	rs121917762	NC_000011.10:2165726:G:T
NM_018105.3(THAP1):c.134T>G (p.Phe45Cys)	THAP1	F45C	Torsion dystonia 6	Pathogenic	criteria provided, single submitter	VCV002584745	8	42694462	8	42839319	2584745	2752308		NC_000008.11:42839318:A:C
NM_018105.3(THAP1):c.115_116insGGCCGGGAGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGCGGATCACGAGGTCANNNNNNNNNNAAAAAAAAAAAAAAAAAAAAAAAGAATGGGAGGCAG (p.Ala38_Ala39insGlyProGlyAlaValAlaHisAlaCysAsnProSerThrLeuGlyGlyArgGlyGlyArgIleThrArgSerXaaXaaXaaXaaLysLysLysLysLysLysLysGluTrpGluAla)	THAP1		Torsion dystonia 6	Pathogenic(Last reviewed: Mar 17, 2022)	criteria provided, single submitter	VCV002113153	8	42694480 - 42694481	8	42839337 - 42839338	2113153	2164441		
NM_018105.3(THAP1):c.11C>T (p.Ser4Phe)	THAP1	S4F	Torsion dystonia 6	Pathogenic(Last reviewed: Nov 3, 2020)	criteria provided, single submitter	VCV001804072	8	42698227	8	42843084	1804072	1861097		NC_000008.11:42843083:G:A
NC_000008.10:g.(?_42693105)_(42698237_?)del	THAP1		Torsion dystonia 6	Pathogenic(Last reviewed: Aug 15, 2021)	criteria provided, single submitter	VCV001458222	8	42693105 - 42698237			1458222	1467937		
NM_018105.3(THAP1):c.348del (p.Ile116fs)	THAP1	I116fs, L51fs	Torsion dystonia 6	Pathogenic(Last reviewed: Oct 11, 2021)	criteria provided, single submitter	VCV001457202	8	42693399	8	42838256	1457202	1477939		NC_000008.11:42838255:AA:A
NM_018105.3(THAP1):c.108G>A (p.Trp36Ter)	THAP1	W36*	Torsion dystonia 6	Pathogenic(Last reviewed: Aug 17, 2021)	criteria provided, single submitter	VCV001406166	8	42694488	8	42839345	1406166	1493427		NC_000008.11:42839344:C:T
NM_018105.3(THAP1):c.1A>T (p.Met1Leu)	THAP1	M1L	Torsion dystonia 6	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001405735	8	42698237	8	42843094	1405735	1480675		NC_000008.11:42843093:T:A
NM_018105.3(THAP1):c.85C>T (p.Arg29Ter)	THAP1	R29*	Torsion dystonia 6	Pathogenic/Likely pathogenic(Last reviewed: Feb 2, 2022)	criteria provided, multiple submitters, no conflicts	VCV001070763	8	42694511	8	42839368	1070763	1061343		NC_000008.11:42839367:G:A
NM_018105.3(THAP1):c.482_485del (p.Lys161fs)	THAP1	K161fs	Torsion dystonia 6	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV001069320	8	42693262 - 42693265	8	42838119 - 42838122	1069320	1061341		NC_000008.11:42838118:TTCTTTCT:TTCT
NM_018105.3(THAP1):c.77C>T (p.Pro26Leu)	THAP1	P26L	Torsion dystonia 6|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000846905	8	42694519	8	42839376	846905	834769	rs1802674870	NC_000008.11:42839375:G:A
NM_018105.3(THAP1):c.71del (p.Lys24fs)	THAP1	K25fs, K24fs	Torsion dystonia 6	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000845954	8	42698167	8	42843024	845954	834770	rs1802756440	NC_000008.11:42843023:TT:T
NM_018105.3(THAP1):c.135_139delinsGGGTTTA (p.Phe45fs)	THAP1	F45fs	not provided|Torsion dystonia 6	Pathogenic(Last reviewed: Sep 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000817036	8	42694457 - 42694461	8	42839314 - 42839318	817036	805577	rs1586457060	NC_000008.11:42839313:GTTTA:TAAACCC
NM_018105.3(THAP1):c.112del (p.Ala38fs)	THAP1	A38fs	Torsion dystonia 6	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000807516	8	42694484	8	42839341	807516	798600	rs1586457084	NC_000008.11:42839340:CC:C
NM_018105.3(THAP1):c.331C>T (p.Gln111Ter)	THAP1	Q111*	Torsion dystonia 6	Pathogenic(Last reviewed: Jul 11, 2022)	criteria provided, single submitter	VCV000654563	8	42693416	8	42838273	654563	637218	rs1586456404	NC_000008.11:42838272:G:A
NM_018105.3(THAP1):c.2T>C (p.Met1Thr)	THAP1	M1T	Torsion dystonia 6	Pathogenic(Last reviewed: Nov 11, 2021)	criteria provided, single submitter	VCV000582441	8	42698236	8	42843093	582441	565139	rs1563646198	NC_000008.11:42843092:A:G
NM_018105.3(THAP1):c.201CAA[2] (p.Asn69del)	THAP1	N69del	not provided|Torsion dystonia 6	Pathogenic(Last reviewed: Aug 1, 2023)	criteria provided, multiple submitters, no conflicts	VCV000569769	8	42694387 - 42694389	8	42839244 - 42839246	569769	567930	rs1563644810	NC_000008.11:42839243:TTGTTGTTG:TTGTTG
NM_018105.3(THAP1):c.305dup (p.Pro103fs)	THAP1	H37fs, P103fs	Torsion dystonia 6	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000568461	8	42693441 - 42693442	8	42838298 - 42838299	568461	562420	rs1563644456	NC_000008.11:42838298:GGGGG:GGGGGG
NM_018105.3(THAP1):c.7C>T (p.Gln3Ter)	THAP1	Q3*	Torsion dystonia 6	Pathogenic(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV000532263	8	42698231	8	42843088	532263	523907	rs1554599983	NC_000008.11:42843087:G:A
NM_018105.3(THAP1):c.289C>T (p.Gln97Ter)	THAP1	Q97*	Torsion dystonia 6	Pathogenic(Last reviewed: Mar 21, 2022)	criteria provided, single submitter	VCV000532262	8	42693458	8	42838315	532262	523898	rs1554599616	NC_000008.11:42838314:G:A
NM_018105.3(THAP1):c.131del (p.Asn44fs)	THAP1	N44fs	Torsion dystonia 6	Pathogenic(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000532261	8	42694465	8	42839322	532261	524172	rs1554599712	NC_000008.11:42839321:TTTTTT:TTTTT
NM_018105.2(THAP1):c.270_273del	THAP1		not provided|Torsion dystonia 6	Pathogenic/Likely pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000444750	8	42693474 - 42693477	8	42838331 - 42838334	444750	438390	rs749414480	NC_000008.11:42838330:TTCTTTCT:TTCT
NM_018105.3(THAP1):c.62C>T (p.Ser21Phe)	THAP1	S21F	Torsion dystonia 6|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000425441	8	42698176	8	42843033	425441	413775	rs1064797344	NC_000008.11:42843032:G:A
NM_018105.3(THAP1):c.68A>C (p.His23Pro)	THAP1	H23P	Torsion dystonia 6	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000031632	8	42698170	8	42843027	31632	40311	rs387907177	NC_000008.11:42843026:T:G
NM_018105.3(THAP1):c.70A>G (p.Lys24Glu)	THAP1	K24E	Torsion dystonia 6	Pathogenic(Last reviewed: Feb 1, 2012)	no assertion criteria provided	VCV000031631	8	42698168	8	42843025	31631	40310	rs387907176	NC_000008.11:42843024:T:C
NM_018105.3(THAP1):c.25G>T (p.Gly9Cys)	THAP1	G9C	Torsion dystonia 6	Pathogenic(Last reviewed: Jan 19, 2010)	no assertion criteria provided	VCV000001651	8	42698213	8	42843070	1651	16690	rs267607112	NC_000008.11:42843069:C:A
NM_018105.3(THAP1):c.474del (p.Lys158fs)	THAP1	K158fs	Torsion dystonia 6	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000001650	8	42693273	8	42838130	1650	16689	rs1586456278	NC_000008.11:42838129:TTTTT:TTTT
NM_018105.3(THAP1):c.388_389del (p.Val131fs)	THAP1	V131fs	Torsion dystonia 6	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000001649	8	42693358 - 42693359	8	42838215 - 42838216	1649	16688	rs1586456350	NC_000008.11:42838214:GAGAGA:GAGA
NM_018105.3(THAP1):c.460del (p.Gln154fs)	THAP1	Q154fs	Torsion dystonia 6	Pathogenic(Last reviewed: May 1, 2009)	no assertion criteria provided	VCV000001647	8	42693287	8	42838144	1647	16686	rs1586456293	NC_000008.11:42838143:G:
NM_004085.4(TIMM8A):c.223C>T (p.Gln75Ter)	TIMM8A	Q75*	Deafness dystonia syndrome	Pathogenic	no assertion criteria provided	VCV001703041	X	100601558	X	101346570	1703041	1695432		NC_000023.11:101346569:G:A
NM_004085.4(TIMM8A):c.181del (p.Ala61fs)	TIMM8A	A61fs	Deafness dystonia syndrome	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001686260	X	100601600	X	101346612	1686260	1678268		NC_000023.11:101346611:CC:C
NC_000023.11:g.101345283_101347393del	TIMM8A		Deafness dystonia syndrome	Pathogenic(Last reviewed: Nov 3, 2021)	no assertion criteria provided	VCV001312519	X	100600269 - 100602379	X	101345281 - 101347391	1312519	1302780		
NM_004085.4(TIMM8A):c.66_67del (p.Ile23fs)	TIMM8A	I23fs	Deafness dystonia syndrome	Pathogenic(Last reviewed: Jul 1, 2021)	no assertion criteria provided	VCV001185085	X	100603586 - 100603587	X	101348598 - 101348599	1185085	1175096		NC_000023.11:101348597:TG:
NC_000023.11:g.(?_101346475)_(101348757_?)del	TIMM8A		Deafness dystonia syndrome	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000929951	X	100601463 - 100603745			929951	918496		
NM_004085.4(TIMM8A):c.127del (p.Cys43fs)	TIMM8A	C43fs	Deafness dystonia syndrome	Pathogenic(Last reviewed: Feb 15, 2006)	no assertion criteria provided	VCV000011326	X	100603526	X	101348538	11326	26365	rs869320667	NC_000023.11:101348537:AAA:AA
NM_004085.4(TIMM8A):c.133-23A>C	TIMM8A		Deafness dystonia syndrome	Pathogenic(Last reviewed: Feb 1, 2005)	no assertion criteria provided	VCV000011325	X	100601671	X	101346683	11325	26364	rs869320666	NC_000023.11:101346682:T:G
NM_004085.4(TIMM8A):c.238C>T (p.Arg80Ter)	TIMM8A	R80*	Deafness dystonia syndrome	Pathogenic(Last reviewed: Jun 1, 2001)	no assertion criteria provided	VCV000011324	X	100601543	X	101346555	11324	26363	rs1054894	NC_000023.11:101346554:G:A
TIMM8A, DEL	TIMM8A		Deafness dystonia syndrome	Pathogenic(Last reviewed: Mar 23, 2004)	no assertion criteria provided	VCV000011323					11323	26362		
NM_004085.4(TIMM8A):c.73del (p.Glu24_Val25insTer)	TIMM8A		Deafness dystonia syndrome	Pathogenic(Last reviewed: Oct 1, 2001)	no assertion criteria provided	VCV000011322	X	100603580	X	101348592	11322	26361	rs869320665	NC_000023.11:101348591:CC:C
NM_004085.4(TIMM8A):c.70G>T (p.Glu24Ter)	TIMM8A	E24*	Deafness dystonia syndrome	Pathogenic(Last reviewed: Apr 20, 2016)	no assertion criteria provided	VCV000011320	X	100603583	X	101348595	11320	26359	rs111033631	NC_000023.11:101348594:C:A
NM_004085.4(TIMM8A):c.148_157del (p.Lys50fs)	TIMM8A	K50fs	Deafness dystonia syndrome	Pathogenic(Last reviewed: May 1, 2023)	criteria provided, single submitter	VCV000011319	X	100601624 - 100601633	X	101346636 - 101346645	11319	26358	rs869320733	NC_000023.11:101346635:GCCCAGGCTTG:G
NM_004085.4(TIMM8A):c.116del (p.Met39fs)	TIMM8A	M39fs	Deafness dystonia syndrome	Pathogenic(Last reviewed: Oct 1, 1996)	no assertion criteria provided	VCV000011318	X	100603537	X	101348549	11318	26357	rs869320664	NC_000023.11:101348548:A:
NM_000113.3(TOR1A):c.461G>A (p.Trp154Ter)	TOR1A	W154*	Early-onset generalized limb-onset dystonia	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001686267	9	132581183	9	129818904	1686267	1678275		NC_000009.12:129818903:C:T
NM_000113.3(TOR1A):c.958A>G (p.Lys320Glu)	TOR1A	K320E	Early-onset generalized limb-onset dystonia	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001686266	9	132576292	9	129814013	1686266	1678274		NC_000009.12:129814012:T:C
NM_000113.3(TOR1A):c.214C>T (p.Gln72Ter)	TOR1A	Q72*	Early-onset generalized limb-onset dystonia	Pathogenic(Last reviewed: Mar 6, 2021)	criteria provided, single submitter	VCV001172768	9	132585090	9	129822811	1172768	1161962		NC_000009.12:129822810:G:A
NM_000113.3(TOR1A):c.862C>T (p.Arg288Ter)	TOR1A	R288*	not provided|Early-onset generalized limb-onset dystonia|Arthrogryposis multiplex congenita 5	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2023)	criteria provided, multiple submitters, no conflicts	VCV000559927	9	132576388	9	129814109	559927	550616	rs760768475	NC_000009.12:129814108:G:A
NM_000113.3(TOR1A):c.863G>A (p.Arg288Gln)	TOR1A	R288Q	not provided	Pathogenic(Last reviewed: Oct 21, 2015)	criteria provided, single submitter	VCV000162491	9	132576387	9	129814108	162491	172165	rs727502811	NC_000009.12:129814107:C:T
NM_000113.3(TOR1A):c.904GAG[1] (p.Glu303del)	TOR1A	E303del	TOR1A-related condition|TOR1A-related disorders|Arthrogryposis multiplex congenita 5|Early-onset generalized limb-onset dystonia|Inborn genetic diseases|Dystonic disorder|not provided|Early-onset generalized limb-onset dystonia	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2023)	criteria provided, multiple submitters, no conflicts	VCV000005180	9	132576341 - 132576343	9	129814062 - 129814064	5180	20219	rs80358233	NC_000009.12:129814061:CTCCTC:CTC
NM_004758.4(TSPOAP1):c.2449_2450inv (p.Gln817Ter)	TSPOAP1	Q817*, Q757*	Dystonia 22, juvenile-onset	Pathogenic(Last reviewed: Jul 31, 2023)	no assertion criteria provided	VCV002574617	17	56389732 - 56389733	17	58312371 - 58312372	2574617	2739550		NC_000017.11:58312370:TG:CA
NM_004758.4(TSPOAP1):c.538del (p.Ala180fs)	TSPOAP1|TSPOAP1-AS1	A180fs	Dystonia 22, juvenile-onset	Pathogenic(Last reviewed: Jul 31, 2023)	no assertion criteria provided	VCV002574616	17	56403686	17	58326325	2574616	2739549		NC_000017.11:58326324:CCC:CC
NM_006087.4(TUBB4A):c.1172G>A (p.Arg391His)	TUBB4A	R442H, R391H, R436H, R319H	Hypomyelinating leukodystrophy 6|not provided	Pathogenic(Last reviewed: May 10, 2023)	criteria provided, multiple submitters, no conflicts	VCV000267793	19	6495338	19	6495327	267793	263149	rs886041021	NC_000019.10:6495326:C:T
NM_006087.4(TUBB4A):c.533C>T (p.Thr178Met)	TUBB4A	T229M, T178M, T106M, T223M	not provided|Torsion dystonia 4	Pathogenic(Last reviewed: Aug 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000267774	19	6495977	19	6495966	267774	263168	rs587777468	NC_000019.10:6495965:G:A
NM_006087.4(TUBB4A):c.1228G>A (p.Glu410Lys)	TUBB4A	E410K, E461K, E338K, E455K	Torsion dystonia 4|Hypomyelinating leukodystrophy 6|Hypomyelinating leukodystrophy 6|not provided|Global developmental delay|Cerebral palsy	Pathogenic/Likely pathogenic(Last reviewed: Jul 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000135658	19	6495282	19	6495271	135658	139376	rs587777428	NC_000019.10:6495270:C:T
NM_006087.4(TUBB4A):c.811G>A (p.Ala271Thr)	TUBB4A	A271T, A322T, A316T, A199T	Torsion dystonia 4	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000092111	19	6495699	19	6495688	92111	97543	rs587777074	NC_000019.10:6495687:C:T
NM_006087.4(TUBB4A):c.745G>A (p.Asp249Asn)	TUBB4A	D249N, D300N, D177N, D294N	Hypomyelinating leukodystrophy 6|Torsion dystonia 4|Hypomyelinating leukodystrophy 6|Abnormality of the nervous system|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2023)	criteria provided, multiple submitters, no conflicts	VCV000050985	19	6495765	19	6495754	50985	65656	rs483352809	NC_000019.10:6495753:C:T
NM_022575.4(VPS16):c.156C>A (p.Asn52Lys)	VPS16	N52K	Dystonia 30	Pathogenic(Last reviewed: Apr 30, 2021)	no assertion criteria provided	VCV001065418	20	2840713	20	2860067	1065418	1053719		NC_000020.11:2860066:C:A
NM_022575.4(VPS16):c.244_259delinsGAGAGC (p.Lys82fs)	VPS16	K82fs	Dystonia 30	Pathogenic(Last reviewed: Apr 30, 2021)	no assertion criteria provided	VCV001065417	20	2840888 - 2840903	20	2860242 - 2860257	1065417	1053718		NC_000020.11:2860241:AAGAGTGGACCCGTGG:GAGAGC
NM_022575.4(VPS16):c.1367+2T>C	VPS16		Dystonia 30	Pathogenic(Last reviewed: Apr 30, 2021)	no assertion criteria provided	VCV001065416	20	2843748	20	2863102	1065416	1053717		NC_000020.11:2863101:T:C
NM_022575.4(VPS16):c.1094_1095dup (p.Tyr366fs)	VPS16	Y366fs	Dystonia 30	Pathogenic(Last reviewed: Apr 30, 2021)	no assertion criteria provided	VCV001065414	20	2843245 - 2843246	20	2862599 - 2862600	1065414	1053715		NC_000020.11:2862599:GAG:GAGAG
NM_022575.4(VPS16):c.1335T>G (p.Tyr445Ter)	VPS16	Y301*, Y445*	VPS16-associated disorder	Pathogenic(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV000976681	20	2843714	20	2863068	976681	964894	rs374769660	NC_000020.11:2863067:T:G
NM_013245.3(VPS4A):c.608G>A (p.Gly203Glu)	VPS4A	G203E	Syndromic congenital hemolytic and dyserythropoietic anemia	Pathogenic(Last reviewed: May 1, 2020)	criteria provided, single submitter	VCV000996555	16	69353434	16	69319531	996555	984271	rs1965484288	NC_000016.10:69319530:G:A
NM_013245.3(VPS4A):c.616G>A (p.Glu206Lys)	VPS4A	E206K	not provided	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV000976852	16	69353442	16	69319539	976852	964985	rs1965484443	NC_000016.10:69319538:G:A
NM_013245.3(VPS4A):c.850A>G (p.Arg284Gly)	VPS4A	R284G	not provided	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV000976851	16	69354671	16	69320768	976851	964986	rs1965499910	NC_000016.10:69320767:A:G
NM_013245.3(VPS4A):c.850A>T (p.Arg284Trp)	VPS4A	R284W	not provided|Syndromic congenital hemolytic and dyserythropoietic anemia	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000976850	16	69354671	16	69320768	976850	964987	rs1965499910	NC_000016.10:69320767:A:T
NG_050658.1:g.(5235_69181)_(69440_100126)del	WARS2		Parkinsonism-dystonia 3, childhood-onset	Pathogenic(Last reviewed: Feb 17, 2022)	no assertion criteria provided	VCV001341956					1341956	1333202		
NM_015836.4(WARS2):c.622G>T (p.Glu208Ter)	WARS2	E114*, E122*, E151*, E185*, E208*, R179L	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	Pathogenic(Last reviewed: Feb 28, 2020)	criteria provided, single submitter	VCV000976753	1	119576730	1	119034107	976753	964795	rs137890886	NC_000001.11:119034106:C:A
